Fatty acid-pharmaceutical agent conjugates

ABSTRACT

The invention provides conjugates of fatty acids and pharmaceutical agents useful in treating noncentral nervous system conditions. Methods for selectively targeting pharmaceutical agents to desired tissues are provided.

BACKGROUND OF THE INVENTION

[0001] Improving drug selectivity for target tissue is an establishedgoal in the medical arts. In general, it is desirable to deliver a drugselectively to its target, so that dosage and, consequently, sideeffects can be reduced. This is particularly the case for toxic agentssuch as anti-cancer agents because achieving therapeutic doses effectivefor treating the cancer is often limited by the toxic side effects ofthe anti-cancer agent on normal, healthy tissue. The problems relatingto lack of drug selectivity can be exemplified by Taxol®.

[0002] Taxol® (paclitaxel) was first isolated in 1971 from the bark ofTaxus brevifolia and was approved in 1992 by the US Food and DrugAdministration for treatment of metastatic ovarian cancer and later forbreast cancer. Its mechanism of action is believed to involve promotingformation and hyperstabilization of microtubules, thereby preventing thedisassembly of microtubules necessary for completion of cell division.It also has been reported that Taxol induces expression of cytokines,affects the activity of kinases and blocks processes essential formetastasis, in as yet uncharacterized mechanisms of action.

[0003] Taxol has attracted unusually strong scientific attention, notonly because of its unique antiproliferative mechanism of action, butalso because it is active against nearly all cancers against which ithas been tested and because it has been discovered to be an analog ofnumerous closely related compounds occurring naturally. These compounds,taxanes, are now recognized as a new class of anticancer compounds.

[0004] Taxol's strength against cancers of diverse tissue origin alsorepresents a significant drawback. An ideal anticancer agent has tissuespecificity, thereby reducing side-effects on normal (dividing) cells.Taxol analogs with tissue specificity therefore are desired. Anotherdrawback of Taxol is its extreme insolubility. Taxol can be administeredeffectively in a solvent including cremophor, which combination canprovoke severe hypersensitive immune responses. As a result of thesedrawbacks, and also as a result of the potential for modifying Taxol atnumerous sites as demonstrated by other naturally-occurring taxanes withanticancer activity, a search for more selective taxanes was launched.

[0005] To date, more than 200 taxanes have been synthesized (orisolated) and tested in vitro or in vivo for anticancer activity. Theresults, however, have been so disappointing that the National CancerInstitute (NCI) generally no longer is interested in testing Taxolanalogs. In general with Taxol analogs, the solubility problems remain,and/or potency is sharply reduced, and/or selectivity is not improved,and/or the ratio of the median toxic dose to the median effective dose(“therapeutic index”) is unacceptably reduced.

[0006] Taxol has the following formula:

[0007] Taxanes have the basic three ring structure (A, B and C),substituted or unsubstituted.

[0008] Taxol's carbons are numbered conventionally as follows:

[0009] Based upon the taxanes tested to date, as many questions havebeen raised as have been answered, and general rules have not beenfashioned easily in predicting selectivity, activity and solubility.Firstly, no rules have emerged regarding selectivity. Those taxanes thatare strongly active appear to have activity as broad as Taxol'sactivity, and no headway appears to have been made in terms ofdeveloping a more selective Taxol analog.

[0010] Some information about activity has emerged. Numeroussubstitutions have been made at C7, C9, C10, C19, R₁ and combinationsthereof while retaining significant, but usually reduced, activity.Substitutions at C2, C4 and 2′OH, however, are generally not tolerated.These conclusions are only generalities, for example, because somesubstitutions at C9-C10 (cyclic derivatives) are not tolerated and somesubstitutions at C2 (meta substitutions on the phenyl) are tolerated.Likewise, the C13 side chain and, in particular, the 2′OH are required,although the minimum structural requirements of the side chain have notbeen determined for therapeutic efficacy.

[0011] Attempts to improve Taxol's solubility have not resulted insuccessful clinical products. One approach has been to manufactureprodrugs of Taxol, which prodrugs undergo in vivo transformation intoTaxol and some other product. Attempts were made to esterify the C7hydroxy and 2′ hydroxy groups, with the hope that the bond would bestable in solution (to permit preferred administration modes-i.v. overat least 24 hours) but would cleave readily in vivo. The groups testedwere all hydrophilic and included amines, short carboxylic acids (usinge.g. succinic anhydride and glutaric anhydride), sulfonic acids, aminoacids and phosphates. Generally, activity was reduced although somesuccess was obtained with certain derivatives. Again, no particularpattern emerged permitting one to predict reliably which groups could besubstituted on Taxol to yield a therapeutically useful product, althoughit was suggested that the 2′ OH derivatives may cleave more easily thanthe C7 OH derivatives.

[0012] Several other factors add to the problem of predicting whichTaxol analogs will be effective. Multiple mechanisms of action have beenproposed in the literature, and a change in one position may have noeffect on activity on one such mechanism but may eliminate activity onanother mechanism. In addition, changes that favorably influenceactivity may unfavorably influence bioavailability. For example, Taxolaffects microtubule formation inside a cell, but a change in structurethat increases intracellular activity may adversely affect the abilityof Taxol to gain entry into a cell. Taxol also is known to bind toproteins, and the effect on activity that results from a change inTaxol's binding to protein (in terms of conformation, cellularabsorption and solubility) is unknown.

[0013] It has been reported that Taxol does not get into the brain,apparently excluded by the blood brain barrier. It is not known why thisis so, as Taxol is lipophilic, gets into cells and might be expected tocross the blood brain barrier.

[0014] Among the most promising of the two hundred analogs tested isTaxotere (docetaxel), because of its slightly increased activity andsolubility. Oddly, however, Taxotere differs from Taxol at sites whichtypically do not have a strong influence on activity, and one would notpredict the improvements in Taxotere from these differences, even inhindsight.

[0015] Taxotere has the following formula:

[0016] Fatty acids previously have been conjugated with drugs to helpthe drugs as conjugates cross the blood brain barrier. DHA(docosahexaenoic acid) is a 22 carbon naturally-occurring, unbranchedfatty acid that previously has been shown to be unusually effective,when conjugated to a drug, in crossing the blood brain barrier. DHA isattached via the acid group to hydrophilic drugs and renders these drugsmore hydrophobic (lipophilic). DHA is an important constituent of thebrain and recently has been approved as an additive to infant formula.It is present in the milk of lactating women. The mechanism of action bywhich DHA helps drugs conjugated to it cross the blood brain barrier isunknown.

[0017] Another example of the conjugation of fatty acids to a drug isthe attachment of pipotiazine to stearic acid, palmitic acid, enanthicacid, undecylenic acid or 2,2-dimethylpalmitic acid. Pipotiazine is adrug that acts within the central nervous system. The purpose ofconjugating pipotiazine to the fatty acids was to create an oilysolution of the drug as a liquid implant for slow release of the drugwhen injected intramuscularly. The release of the drug appeared todepend on the particular fatty acid selected, and the drug was testedfor its activity in the central nervous system.

[0018] Lipidic molecules, including the fatty acids, also have beenconjugated with drugs to render the conjugates more lipophilic than thedrug. In general, increased lipophilicity has been suggested as amechanism for enhancing intestinal uptake of drugs into the lymphaticsystem, thereby enhancing the entry of the conjugate into the brain andalso thereby avoiding first-pass metabolism of the conjugate in theliver. The type of lipidic molecules employed have includedphospholipids, non-naturally occurring branched and unbranched fattyacids, and naturally occurring branched and unbranched fatty acidsranging from as few as 4 carbon atoms to more than 30 carbon atoms. Inone instance, enhanced receptor binding activity was observed (for anadenosine receptor agonist), and it was postulated that the pendantlipid molecule interacted with the phospholipid membrane to act as adistill anchor for the receptor ligand in the membrane micro environmentof the receptor. This increase in potency, however, was not observedwhen the same lipid derivatives of adenosine receptor antagonists wereused, and generalizations thus were not made possible by those studies.

SUMMARY OF THE INVENTION

[0019] The present invention involves the unexpected finding thatconjugates of pharmaceutical agents and a highly lipophilic group, aC8-C26, naturally ocurring, unbranched carbon chain, have a differentselectivity relative to the unconjugated pharmaceutical agents.

[0020] In one embodiment, the conjugates render the activity of theseconjugates selective, in general, for colon tissue, breast tissue andcentral nervous system tissue (“targeted tissues”). The conjugates, alsounexpectedly, restrict the activity of these conjugates to cell typeswithin these tissue categories relative to that of the unconjugatedpharmaceutical agents. The conjugates, further unexpectedly, can reducesharply the activity of these conjugates relative to that of theunconjugated pharmaceutical agents in most cell lines of tissue typesother than colon, breast, and central nervous system, thereby reducingpotential side effects of the conjugates versus those of theunconjugated pharmaceutical agents. The therapeutic index of theconjugates is improved, versus that of the unconjugated pharmaceuticalagents.

[0021] According to one aspect of the invention, a method is providedfor targeting a therapeutic agent to a noncentral nervous system tissueto treat a noncentral nervous system condition. A conjugate of a C8-C22,unbranched, naturally occurring fatty acid and a pharmaceutical agent isadministered to a subject in need of such treatment. In certainembodiments, the tissue is breast tissue, gastrointestinal tissue andovarian tissue and the condition calls for treatment of breast tissue,gastrointestinal tissue or ovarian tissue, respectively. In otherembodiments, the tissue can be tissue of the Blood and Blood Formingsystem: including platelets, blood vessel wall, and bone marrow;Cardiovascular system: including heart and vascular system; Digestiveand excretory system: including alimentary tract, biliary tract, kidney,liver, pancreas and urinary tract; Endocrine system: including adrenalgland, kidney, ovary, pituitary gland, renal gland, salivary gland,sebaceous gland, testis, thymus gland and thyroid gland; Muscularsystem: including muscles that move the body. Reproductive System:including breast, ovary, penis and uterus; Respiratory system: includingbronchus, lung and trachea; Skeletal system: including bones and joints;Tissue, fiber, and integumentary system: including adipose tissue,cartilage, connective tissue, cuticle, dermis, epidermis, epithelium,fascia, hair follicle, ligament, bone marrow, melanin, melanocyte,mucous membrane, skin, soft tissue, synovial capsule and tendon.

[0022] Unbranched, naturally occurring fatty acids embraced by theinvention include C8:0 (caprylic acid), C10:0 (capric acid), C12:0(lauric acid), C14:0 (myristic acid), C16:0 (palmitic acid), C16:1(palmitoleic acid), C16:2, C18:0 (stearic acid), C18:1 (oleic acid),C18:1-7 (vaccenic), C18:2-6 (linoleic acid), C18:3-3 (α-linolenic acid),C18:3-5 (eleostearic), C18:3-6 (δ-linolenic acid), C18:4-3, C20:1(gondoic acid), C20:2-6, C20:3-6 (dihomo-y-linolenic acid), C20:4-3,C20:4-6 (arachidonic acid), C20:5-3 (eicosapentaenoic acid), C22:1(docosenoic acid), C22:4-6 (docosatetraenoic acid), C22:5-6(docosapentaenoic acid), C22:5-3 (docosapentaenoic), C22:6-3(docosahexaenoic acid) and C24:1-9 (nervonic). Highly preferredunbranched, naturally occurring fatty acids are those with between 14and 22 carbon atoms. The most preferred fatty acid is docosahexaenoicacid.

[0023] It is preferred that the conjugate be of a single fatty acidmolecule and the covalent attachment be directly to the pharmaceuticalagent (i.e., free of a linker molecule between the active pharmaceuticalagent and the fatty acid.

[0024] The pharmaceutical agent may be any pharmacological compound ordiagnostic agent, as desired. The pharmaceutical agent, however, is notan adenosine receptor agonist or antagonist. The pharmaceutical agent,of course, has an activity outside of the central nervous system.

[0025] Examples of catagories of pharmaceutical agents include:adrenergic agent; adrenocortical steroid; adrenocortical suppressant;alcohol deterrent; aldosterone antagonist; amino acid; ammoniadetoxicant; anabolic; analeptic; analgesic; androgen; anesthesia,adjunct to; anesthetic; anorectic; antagonist; anterior pituitarysuppressant; anthelmintic; anti-acne agent; anti-adrenergic;anti-allergic; anti-amebic; anti-androgen; anti-anemic; anti-anginal;anti-anxiety; anti-arthritic; anti-asthmatic; anti-atherosclerotic;antibacterial; anticholelithic; anticholelithogenic; anticholinergic;anticoagulant; anticoccidal; anticonvulsant; antidepressant;antidiabetic; antidiarrheal; antidiuretic; antidote; anti-emetic;anti-epileptic; anti-estrogen; antifibrinolytic; antifungal;antiglaucomaagent; antihemophilic; antihemorrhagic; antihistamine;antihyperlipidemia; antihyperlipoproteinemic; antihypertensive;antihypotensive; anti-infective; anti-infective, topical;anti-inflammatory; antikeratinizing agent; antimalarial; antimicrobial;antimigraine; antimitotic; antimycotic, antinauseant, antineoplastic,antineutropenic, antiobessional agent; antiparasitic; antiparkinsonian;antiperistaltic, antipneumocystic; antiproliferative; antiprostatichypertrophy; antiprotozoal; antipruritic; antipsychotic; antirheumatic;antischistosomal; antiseborrheic; antisecretory; antispasmodic;antithrombotic; antitussive; anti-ulcerative; anti-urolithic; antiviral;appetite suppressant; benign prostatic hyperplasia therapy agent; bloodglucose regulator; bone resorption inhibitor; bronchodilator; carbonicanhydrase inhibitor; cardiac depressant; cardioprotectant; cardiotonic;cardiovascular agent; choleretic; cholinergic; cholinergic agonist;cholinesterase deactivator; coccidiostat; cognition adjuvant; cognitionenhancer; depressant; diagnostic aid; diuretic; dopaminergic agent;ectoparasiticide; emetic; enzyme inhibitor; estrogen; fibrinolytic;fluorescent agent; free oxygen radical scavenger; gastrointestinalmotility effector; glucocorticoid; gonad-stimulating principle; hairgrowth stimulant; hemostatic; histamine H2 receptor antagonists;hormone; hypocholesterolemic; hypoglycemic; hypolipidemic; hypotensive;imaging agent; immunizing agent; immunomodulator; immunoregulator;immunostimulant; immunosuppressant; impotence therapy adjunct;inhibitor; keratolytic; LHRH agonist; liver disorder treatment;luteolysin; memory adjuvant; mental performance enhancer; moodregulator; mucolytic; mucosal protective agent; mydriatic; nasaldecongestant; neuromuscular blocking agent; neuroprotective; NMDAantagonist; non-hormonal sterol derivative; oxytocic; plasminogenactivator; platelet activating factor antagonist; platelet aggregationinhibitor; post-stroke and post-head trauma treatment; potentiator;progestin; prostaglandin; prostate growth inhibitor; prothyrotropin;psychotropic; pulmonary surface; radioactive agent; regulator; relaxant;repartitioning agent; scabicide; sclerosing agent; sedative;sedative-hypnotic; selective adenosine Al antagonist; serotoninantagonist; serotonin inhibitor; serotonin receptor antagonist; steroid;stimulant; suppressant; symptomatic multiple sclerosis; synergist;thyroid hormone; thyroid inhibitor; thyromimetic; tranquilizer;amyotrophic lateral sclerosis agent; cerebral ischemia agent; Paget'sdisease agent; unstable angina agent; uricosuric; vasoconstrictor;vasodilator; vulnerary; wound healing agent; xanthine oxidase inhibitor.

[0026] In one particularly preferred embodiment of the invention, thedrug is an anti-cancer agent. Examples of anti-cancer agents aredescribed in greater detail in the specification. Included are thetaxanes, (e.g., Taxol and Taxotere). Conjugates of C8-C22, unbranched,naturally occurring fatty acids and taxoids also are embraced by theinvention.

[0027] C8-C26 fatty acids previously have been conjugated to drugs thatare active in the central nervous system. The invention thus alsocontemplates the use of C8-C22, unbranched, naturally occurring fattyacids in the manufacture of a medicament for treating a noncentralnervous system condition. The invention further contemplatescompositions of matter that are conjugates of C8-C22, unbranched,naturally occurring fatty acids and noncentral nervous system activepharmaceutical agents.

[0028] A noncentral nervous system active pharmaceutical agent is onethat has no function or use in the central nervous system. Its onlytherapeutic use is outside of the central nervous system. Examples ofsuch pharmaceutical agents include, but are not limited to: Bloodglucose regulators, such as tolazamide, tolbutamide, chlorpropamide,acetohexamide, and, glipizide; HMGcoA reductase inhibitors, such asLovastatin (Mevacor), Simvastatin (Zocor), Pravastatin (Pravachol), and,Fluvstatin (Lescol); Muscosal Protectives, such as Misoprostol(Cytotec); Gastrointestinal Motality affectors, such as Cisapride(Propulsid), Metoclopramide (Reglan), and, Hyoscyamine (Levsin);Antidiarrheals, such as Diphenoxylate hydrochloride (Lomotil),Metronidazole (Flagyl), Methylprednisolone (Medrol), and, Sulfasalazine(Azulfidine); and Hormones for treating, inter alia, ovarian conditions,such as Progesterone, Norgestrel, Norethynodrel, Norethindrone,Levonorgestrel, Ethyndiol, Mestranol, Estrone, Equilin, 17 alphadihydroequilin, equilenin, 17 alpha dihydroequilenin, 17 alpha esradiol,27 bea estradiol, Leuprolide (Lupron), Testolactone, Climiphene,urofollitropin, bromocriptine, gonadorelin, danazol,dehydroepiandrosterone, androstenedione, dihydrotestosterone, Relaxin,folliculostatin, Follicle regulatory protein, Gonadocrinins, Oocytematuration inhibitor and, Insulin growth factor. Other compounds aredetailed below.

[0029] The methods of the invention are useful for treating a variety ofmedical conditions including conditions involving abnormalmammalian-cell proliferation. They further are useful in treatingdiabetes and its complications, excess acid secretion, cardiovascularconditions involving cholesterol (e.g., hyperlipidemia andhypercholesterolemia), diarrhea, ovarian diseases (e.g. endometriosis,ovarian cysts, etc.) and as contraceptive agents. Other conditionstreatable according to the invention will be apparent to those skilledin the art based upon the disclosure and lists of compounds provided.

[0030] The methods and/or products of the invention also are useful intreating conditions specific to noncentral nervous system tissue. Suchconditions can be specific to any of the tissues described above,including breast, gastrointestinal and ovarian tissue.

BRIEF DESCRIPTION OF THE DRAWINGS

[0031]FIG. 1 is a graph plotting concentration of conjugate 1 versuspercent growth of leukemia cells.

[0032]FIG. 2 is a graph plotting concentration of conjugate 1 versuspercent growth of non-small cell lung cancer cells.

[0033]FIG. 3 is a graph plotting concentration of conjugate 1 versuspercent growth of colon cancer cells.

[0034]FIG. 4 is a graph plotting concentration of conjugate 1 versuspercent growth of CNS cancer cells.

[0035]FIG. 5 is a graph plotting concentration of conjugate 1 versuspercent growth of melanoma cells.

[0036]FIG. 6 is a graph plotting concentration of conjugate 1 versuspercent growth of ovarian cancer cells.

[0037]FIG. 7 is a graph plotting concentration of conjugate 1 versuspercent growth of renal cancer cells.

[0038]FIG. 8 is a graph plotting concentration of conjugate 1 versuspercent growth of prostate cancer cells.

[0039]FIG. 9 is a graph plotting concentration of conjugate 1 versuspercent growth of breast cancer cells.

[0040]FIG. 10 is a graph plotting concentration of conjugate 2 versuspercent growth of leukemia cells.

[0041]FIG. 11 is a graph plotting concentration of conjugate 2 versuspercent growth of non-small cell lung cancer cells.

[0042]FIG. 12 is a graph plotting concentration of conjugate 2 versuspercent growth of colon cancer cells.

[0043]FIG. 13 is a graph plotting concentration of conjugate 2 versuspercent growth of CNS cancer cells.

[0044]FIG. 14 is a graph plotting concentration of conjugate 2 versuspercent growth of melanoma cells.

[0045]FIG. 15 is a graph plotting concentration of conjugate 2 versuspercent growth of ovarian cancer cells.

[0046]FIG. 16 is a graph plotting concentration of conjugate 2 versuspercent growth of renal cancer cells.

[0047]FIG. 17 is a graph plotting concentration of conjugate 2 versuspercent growth of prostate cancer cells.

[0048]FIG. 18 is a graph plotting concentration of conjugate 2 versuspercent growth of breast cancer cells.

[0049]FIG. 19 is a graph plotting concentration of Taxol versus percentgrowth of leukemia cells.

[0050]FIG. 20 is a graph plotting concentration of Taxol versus percentgrowth of non-small cell lung cancer cells.

[0051]FIG. 21 is a graph plotting concentration of Taxol versus percentgrowth of colon cancer cells.

[0052]FIG. 22 is a graph plotting concentration of Taxol versus percentgrowth of CNS cancer cells.

[0053]FIG. 23 is a graph plotting concentration of Taxol versus percentgrowth of melanoma cells.

[0054]FIG. 24 is a graph plotting concentration of Taxol versus percentgrowth of ovarian cancer cells.

[0055]FIG. 25 is a graph plotting concentration of Taxol versus percentgrowth of renal cancer cells.

[0056]FIG. 26 is a graph plotting concentration of Taxol versus percentgrowth of prostate cancer cells.

[0057]FIG. 27 is a graph plotting concentration of Taxol versus percentgrowth of breast cancer cells.

DETAILED DESCRIPTION OF THE INVENTION

[0058] cis-docosahexaenoic acid (DHA) is a naturally occurring fattyacid. It is an unbranched chain fatty acid with six double bonds, allcis. Its structure is as follows:

[0059] DHA can be isolated, for example, from fish oil or can bechemically synthesized. These methods, however, can generate transisomers, which are difficult and expensive to separate and which maypresent safety problems in humans. The preferred method of production isbiological synthesis to produce the all cis isomer. The preferred sourceof DHA is from Martek Biosciences Corporation of Columbia, Md. Martekhas a patented system for manufacturing DHA using microalgae whichsynthesize only a single isomer of DHA, the all cis isomer. Martek'spatents include U.S. Pat. Nos. 5,374,657, 5,492,938, 5,407,957 and5,397,591.

[0060] DHA also is present in the milk of lactating women, and Martek'slicensee has obtained approval in Europe of DHA as a nutritionalsupplement for infant formula.

[0061] It is known that DHA can be unstable in the presence of oxygen.To stablizie DHA and its conjugates it is important to add anti-oxidantsto the material after it is synthesized. One method of stablization isto make-up the newly synthesized material in the following solution: 100g neat DHA-taxol plus 100 g of vehicle (100 ml propylene glycol, 70 mgalph-tocopherol, 5 mg dialaurylthiodipropionic acid, 50 mg ascorbicacid) prepared and held under argon in amber, sealed vials and stored atfour degrees centigrade. The following anti-oxidants may also beemployed: ascorbic acid, ascorbyl palmitate, dilauryl ascorbate,hydroquinone, butyated hydroxyanisole, sodium meta bisulfite, t-Bcarotene and x-tocopherol. A heavy metal chelator such asethylenediamine tetra-acetic acid (EDTA) may also be used.

[0062] Paclitaxel was first isolated from the bark of Taxus brevifolia(Wani et al., J. Am. Chem. Soc., 93, 2325, 1971). Its isolation andsynthesis have been reported extensively in the literature. Applicantsobtained paclitaxel from a commercial source, Hauser Laboratories, ofBoulder, Colo.

[0063] A solution of Taxol (41 μmol) in methylene chloride (2.5mL) underargon was mixed with 4-dimethylaminopyridine (41 μmol),dicyclohexylcarbodiimide (82 μmol), and DHA (41 μmol) and the reactionmixture was stirred at ambient temperature for two hours. Followingdilution with ether, the reaction mixture was washed with 5%hydrochloric acid, water, saturated aqueous sodium chloride, dried, andconcentrated. Radial chromatography of the residue produced 45mg (94%)of crystalline Taxol-DHA conjugate 1.

[0064] The production of analog 2 involves several steps including anumber of protection-acylation-deprotection steps. A solution of Taxol(59 μmol) in methylene chloride (2.5 mL) was mixed at ambienttemperature under argon with imidazole (147 μmol) and triethylsilylchloride (147 μmol). The reaction mixture was stirred for thirtyminutes, diluted with additional methylene chloride, washed with water,saturated aqueous sodium chloride, dried, and concentrated.Chromatography of the residue produced 50 mg (88%) of intermediate Aplus 5 mg of the 2′, 7-di(triethylsilyl) ether derivative. A solution ofintermediate A (52 μmol) in methylene chloride (3 mL) was mixed atambient temperature under argon with 4-dimethylaminopyridine (52 μmol),dicyclohexylcarbodiimide (104 μmol), and DHA (52 μmol). The reactionmixture was stirred for ten hours, diluted with ether, passed throughcelite, and concentrated. Chromatography of the residue produced 65.9 mgof intermediate B. A solution of intermediate B (51 μmol) inacetonitrile (2 mL) at 0° C. under argon was mixed with 49% aqueous HF(0.2 mL) and the reaction mixture was stirred for one hour. Afterdilution with ether, the reaction mixture was washed with water,saturated aqueous sodium chloride, dried, and concentrated. Radialchromatography of the residue produced 44.6 mg (75%) of Taxol-DHAconjugate 2.

EXAMPLE 3

[0065] Conjugates 1 and 2 were sent to the United States National CancerInstitute (NCI) for screening in the NCI's anticancer screening program.The conjugates were provided in ethanol (approximately 40 mg analog/2 mlethanol). The conjugates were sealed in vials under argon to avoidexposure of the conjugates to oxygen because the conjugates werebelieved to be sensitive to oxygen. Instructions were provided to storeat 4° C. and to open the vials only when ready for immediateexperimental use. Instructions also were provided to use the ethanolsolutions containing the conjugates directly or to dissolve the analogsfurther in DMSO (dimethylsulfoxide) at appropriate concentrations, withvortexing if necessary for adequate dispersal.

[0066] The activities of conjugates 1 and 2 were tested against 57cancer cell lines. The results are presented in FIGS. 1-9 for conjugate1, FIGS. 10-18 for conjugate 2 and FIGS. 19-27 for Taxol. To understandthe data, reference is made to the guides provided by the NCI, excerptedas follows:

[0067] The Calculated Measurement of Effect: Percentage Growth (PG)

[0068] The measured effect of the compound on a cell line is currentlycalculated according to one or the other of the following twoexpressions:

[0069] If (Mean OD_(test)−Mean OD_(tzero))≧0, then

[0070] PG=100×(Mean OD_(test)−Mean OD_(tzero))/(Mean OD_(ctrl)−MeanOd_(tzero))

[0071] If (Mean OD_(test)−Mean OD_(tzero))<0, then

[0072] PG=100×(Mean OD_(test)−Mean Od_(tzero))/Mean Od_(tzero)

[0073] Where:

[0074] Mean OD_(tzero)=The average of optical density measurements ofSRB-derived color just before exposure of cells to the test compound.

[0075] Mean OD_(test)=The average of optical density measurements ofSRB-derived color after 48 hours exposure of cells to the test compound.

[0076] Mean OD_(ctrl)=The average of optical density measurements ofSRB-derived color after 48 hours with no exposure of cells to the testcompound.

[0077] Experimental data was collected against each cell line, . . .Each concentration is expressed as the log₁₀ (molar or μg/ml), . . . Theresponse parameters GI50, TGI, and LC50 are interpolated valuesrepresenting the concentrations at which the PG is +50, 0, and −50,respectively. Sometimes these response parameters cannot be obtained byinterpolation. If, for instance, all of the PGs in a given row exceed+50, then none of the three parameters can be obtained by interpolation.In such a case, the value given for each response parameter is thehighest concentration tested, . . . This practice is extended similarlyto the other possible situations where a response parameter cannot beobtained by interpolation.

[0078] Dose-Response Curves:

[0079] The dose-response curve page of the data package is created byplotting the PGs against the log₁₀ of the corresponding concentrationfor every cell line. The cell line curves are grouped by subpanel.Horizontal lines are provided at the PG values of +50, 0, and −50. Theconcentrations corresponding to points where the curves cross theselines are the GI50, TGI and LC50, respectively.

[0080] Several important distinctions are apparent from the data. Mostimportant, the patterns of anticancer actively for conjugates 1 and 2differ from that of Taxol. In one sense, conjugates 1 and 2 areeffective anticancer agents against a more restricted set of cancer celllines. For example, conjugates 1 and 2 were not very effective againstany of the six leukemia cancer cell lines tested, whereas Taxol wassomewhat effective against all four leukemia cell lines against whichTaxol was tested. (See FIGS. 1, 10 and 19.)

[0081] The relative activity against members within a class of cancersalso was altered. For example, at TGI (horizontal line at zero in thegraphs), Taxol was more effective against non-small cell lung cancerline H522 than against H460 (by about 3 logs), whereas conjugates 1 and2 were slightly more effective against H460 than H522. As anotherexample, Taxol was least effective at TGI against CNSU251, whereasconjugate 1 was most effective against CNSU251 and conjugates 2 was alsovery effective against CNSU251(relative to other CNS cell lines). As afurther example, Taxol was equivalent in activity toward MDA-N andMDA-MB-435 breast cancer cell lines at all concentrations tested,whereas conjugates 1 and 2 were more effective against MDA-N thanMDA-MB-435 at all concentrations tested.

[0082] To further illustrate the differences in the activity ofconjugates 1 and 2 versus that of Taxol, the NCI subjected the data to astatistical analysis designed by the NCI to reflect differences in thepattern of activity of anticancer agents. Conjugate 1 and conjugate 2were determined to be statistically different in their pattern ofactivity versus Taxol in this unique measurement by the NCI.

[0083] It also is to be noted that, in general, conjugates 1 and 2 wereone thousand to ten thousand times less potent than Taxol for many celllines tested. This reduction in activity is important, especially sinceconjugates 1 and 2 maintained strong activity against some cell lines.Conjugates 1 and 2 will be sufficiently active against certain celllines, but will have, on average, a substantially and disproportionatelylower activity against other cell lines, reducing potential sideeffects. For example, the TGI for Taxol against CNS SF-539 is −6.95, andthe TGI for conjugate 1 against this cell line is −5.13 and forconjugate 2 is −5.53. (In other words, the activity of the conjugateswas reduced versus that of Taxol by less than 2 logs). The GI50 forTaxol against CNS SF 539 is −7.52, whereas the GI50s for conjugates 1and 2 are −6.22 and −5.56, respectively (again less than 2 logsdifference). In contrast, Taxol has a GI50 for cell line CNSSF 268 ofless than −10.0, whereas conjugates 1 and 2 have GI50s for CNSSF 268 of5.36 and 5.28, respectively. This represents a reduction of activity inthe conjugates vs. that of Taxol by at least about 5 logs activity! Onaverage, the GI50 for Taxol across all cell lines tested is at least−9.19. (It is probably much higher since concentrations less than −10were not tested, and if Taxol was active at −10.0, −10 (instead of theactual lower value) was used in calculating the average of −9.19. Therewere 27 instances when this occurred.) The average GI50s for conjugates1 and 2 , on the other hand, were 5.49 and 5.22, respectively.Therefore, the average difference in activity for Taxol vs. theconjugates is at least between 3 and 4 logs. Thus, the sharp reductionin the activity of the conjugates against many cell lines vs. a lesserreduction for other cell lines is expected to reduce the potential sideeffects of the conjugates versus those of Taxol at effective doses.

[0084] Cancers other than CNS, breast and colon cancer can be treated.For example, there was activity against non-small cell lung cancercells, melanoma cells and ovarian cancer cells. However, the activitywas relatively reduced and was extremely specific, limiting the utilityof the conjugates for treating generally such cancers. In any event,cancer patients could be evaluated to determine if a conjugate isstrongly active against the patient's cancer prior to selecting theconjugate as the anti-cancer agent of choice for that patient.

[0085] The foregoing experiments establish that DHA analogs have alteredspecificity versus that of Taxol for cancer cell lines. Because of thisaltered specificity, it also is clear that the conjugates themselves aregaining access into the target cells (as opposed to simply releasingTaxol into the environment outside of the cell). Thus, the DHA moietyappears to selectively target certain cell types as opposed to others.The ability of the conjugates to gain entry into the targeted cells wasunknown prior to the invention, and the ability of the DHA moiety toselectively target certain cell types was unexpected.

[0086] The same is true of DHA-Taxotere covalent conjugates, examples ofwhich are presented below. Taxotere's synthesis has been reportedextensively in the literature. One example is Kanazawa, A. et al., J.Organic Chem. 1994, Vol. 59, pp. 1238-1240.

[0087] A solution of Taxotere in methylene chloride under argon is mixedwith 4-dimethylaminopyridine, dicyclohexylcarbodiimide, and DHA. Thereaction mixture is stirred at ambient temperature. Radialchromatography of the residue is performed to produce Taxotere-DHAconjugate 3.

[0088] A solution of Taxotere in dimethylformamide is mixed at ambienttemperature under argon with imidazole and triethylsilyl chloride. Thereaction mixture is stirred at ambient temperature, diluted withmethylene chloride, washed with water, saturated acqueous sodiumchloride, dried, and concentrated. Radial chromatography of the residueis performed to produce intermediate C. A solution of intermediate C inmethylene chloride is mixed at ambient temperature under argon with 4dimethylaminopyridine, dicyclohexylcarbodiimide, and DHA. The reactionmixture is stirred at ambient temperature, diluted with ether, passedthrough celite, and concentrated. Radial chromatography of the residueis performed to produce intermediate D. A solution of intermediate D inacctonitrile at 0° C. under argon is mixed with 49% aqueous HF and thereaction mixture is stirred at the same temperature. After dilution withether, the reaction mixture is washed with water, saturated aqueoussodium chloride, dried, and concentrated Radial chromatography of theresidue is performed to produce Taxotere-DHA conjugate 4.

[0089] A solution of Taxotere in dimethylformamide is mixed at ambienttemperature under argon with imidazole and tert-butylydimethylsilylchloride. The reaction mixture is stirred at ambient temperature,diluted with methylene chloride, washed with water, saturated aqueoussodium chloride, dried, and concentrated. Radial chromatography of theresidue is performed to produce intermediate E. A solution ofintermediate E in methylene chloride is mixed at ambient temperatureunder argon with 4-dimethylaminopyridine, dicyclohexylcarbodiimide, and1 equivalent of DHA. The reaction mixture is stirred at ambienttemperature, diluted with ether, passed through celite, andconcentrated. Radial chromatography of the residue is performed toproduce intermediate F. (Intermediate H also is obtained and used inExample 8 below.) A solution of intermediate F in acetonitrile at 0° C.under argon is mixed with aqueous HF and the reaction mixture is stirredat the same temperature. After dilution with ether, the reaction mixtureis washed with water, saturated aqueous sodium chloride, dried, andconcentrated Radial chromatography of the residue is performed toproduce Taxotere-DHA conjugate 4.

[0090] A solution of Taxotere in dimethylformamide is mixed at ambienttemperature under argon with imidazole and tert-butylydimethylsilylchloride. The reaction mixture is stirred at ambient temperature,diluted with methylene chloride, washed with water, saturated aqueoussodium chloride, dried, and concentrated. Radial chromatography of theresidue is performed to produce intermediate E. A solution ofintermediate E in methylene chloride is mixed at ambient temperatureunder argon with 4-dimethylaminopyridine, dicyclohexylcarbodiimide, andDHA. The reaction mixture is stirred at ambient temperature, dilutedwith ether, passed through celite, and concentrated. Radialchromatography of the residue is performed to produce intermediate G. Asolution of intermediate G in acetonitrile at 0° C. under argon is mixedwith aqueous HF and the reaction mixture is stirred at the sametemperature. After dilution with ether, the reaction mixture is washedwith water, saturated aqueous sodium chloride, dried, and concentrated.Radial chromatography of the residue is performed to produceTaxotere-DHA conjugate 5.

[0091] A solution of taxotere in dimethylformamide is mixed at ambienttemperature under argon with imidazole and tert-butylydimethylsilylchloride. The reaction mixture is stirred at ambient temperature,diluted with methylene chloride, washed with water, saturated aqueoussodium chloride, dried, and concentrated. Radial chromatography of theresidue is performed to produce intermediate E. A solution ofintermediate E in methylene chloride is mixed at ambient temperatureunder argon with 4-dimethylaminopyridine, dicyclohexylcarbodiimide, and1 equivalent of DHA. The reaction mixture is stirred at ambienttemperature, diluted with ether, passed through celite, andconcentrated. Radial chromatography of the residue i performed toproduce intermediate H (and intermediate F which was used above onExample 6. A solution of intermediate H in acetonitrite at 0° C. underargon is mixed with aqueous HF and the reaction mixture is stirred atthe same temperature. After dilution with ether, the reaction mixture iswashed with water, saturated aqueous sodium chloride, dried, andconcentrated. Radial chromatography of the residue is performed toproduce Taxotere-DHA conjugate 6.

[0092] DHA and other naturally occurring, unbranched fatty acids may beconjugated to virtually any drug compound or diagnostic agent and usedaccording to the methods of the present invention so long as thepharmaceutical agent has a use outside of the central nervous system.Pharmaceutical agents include the following categories and specificexamples. It is not intended that the category be limited by thespecific examples. Those of ordinary skill in the art will be able toidentify readily those pharmaceutical agents that have utility outsideof the central nervous system. Those of ordinary skill in the art willrecognize also numerous other compounds that fall within the categoriesand that are useful according to the invention.

[0093] Adrenergic: Adrenalone; Amidephrine Mesylate; ApraclonidineHydrochloride; Brimonidine Tartrate; Dapiprazole Hydrochloride;Deterenol Hydrochloride; Dipivefrin; Dopamine Hydrochloride; EphedrineSulfate; Epinephrine; Epinephrine Bitartrate; Epinephryl Borate;Esproquin Hydrochloride; Etafedrine Hydrochloride; HydroxyamphetamineHydrobromide; Levonordefrin; Mephentermine Sulfate; MetaraminolBitartrate; Metizoline Hydrochloride; Naphazoline Hydrochloride;Norepinephrine Bitartrate; Oxidopamine; Oxymetazoline Hydrochloride;Phenylephrine Hydrochloride; Phenylpropanolamine Hydrochloride;Phenylpropanolamine Polistirex; Prenalterol Hydrochloride;Propylhexedrine; Pseudoephedrine Hydrochloride; TetrahydrozolineHydrochloride; Tramazoline Hydrochloride; Xylometazoline Hydrochloride.

[0094] Adrenocortical steroid: Ciprocinonide; DesoxycorticosteroneAcetate; Desoxycorticosterone Pivalate; Dexamethasone Acetate;Fludrocortisone Acetate; Flumoxonide; Hydrocortisone Hemisuccinate;Methylprednisolone Hemisuccinate; Naflocort; Procinonide; TimobesoneAcetate; Tipredane.

[0095] Adrenocortical suppressant: Aminoglutethimide; Trilostane.

[0096] Alcohol deterrent: Disulfiram.

[0097] Aldosterone antagonist: Canrenoate Potassium; Canrenone;Dicirenone; Mexrenoate Potassium; Prorenoate Potassium; Spironolactone.

[0098] Amino acid: Alanine; Aspartic Acid; Cysteine Hydrochloride;Cystine; Histidine; Isoleucine; Leucine; Lysine; Lysine Acetate; LysineHydrochloride; Methionine; Phenylalanine; Proline; Serine; Threonine;Tryptophan; Tyrosine; Valine.

[0099] Ammonia detoxicant: Arginine: Arginine Glutamate; ArginineHydrochloride.

[0100] Anabolic: Bolandiol Dipropionate; Bolasterone; BoldenoneUndecylenate; Bolenol; Bolmantalate; Ethylestrenol; Methenolone Acetate;Methenolone Enanthate; Mibolerone; Nandrolone Cyclotate; Norbolethone;Pizotyline; Quinbolone; Stenbolone Acetate; Tibolone; Zeranol.

[0101] Analeptic: Modafinil.

[0102] Analgesic: Acetaminophen; Alfentanil Hydrochloride; AminobenzoatePotassium; Aminobenzoate Sodium; Anidoxime; Anileridine; AnileridineHydrochloride; Anilopam Hydrochloride; Anirolac; Antipyrine; Aspirin;Benoxaprofen; Benzydamine Hydrochloride; Bicifadine Hydrochloride;Brifentanil Hydrochloride; Bromadoline Maleate; Bromfenac Sodium;Buprenorphine Hydrochloride; Butacetin; Butixirate; Butorphanol;Butorphanol Tartrate; Carbamazepine; Carbaspirin Calcium; CarbipheneHydrochloride; Carfentanil Citrate; Ciprefadol Succinate; Ciramadol;Ciramadol Hydrochloride; Clonixeril; Clonixin; Codeine; CodeinePhosphate; Codeine Sulfate; Conorphone Hydrochloride; Cyclazocine;Dexoxadrol Hydrochloride; Dexpemedolac; Dezocine; Diflunisal;Dihydrocodeine Bitartrate; Dimefadane; Dipyrone; DoxpicomineHydrochloride; Drinidene; Enadoline Hydrochloride; Epirizole; ErgotamineTartrate; Ethoxazene Hydrochloride; Etofenamate; Eugenol; Fenoprofen;Fenoprofen Calcium; Fentanyl Citrate; Floctafenine; Flufenisal;Flunixin; Flunixin Meglumine; Flupirtine Maleate; Fluproquazone;Fluradoline Hydrochloride; Flurbiprofen; Hydromorphone Hydrochloride;Ibufenac; Indoprofen; Ketazocine; Ketorfanol; Ketorolac Tromethamine;Letimide Hydrochloride; Levomethadyl Acetate; Levomethadyl AcetateHydrochloride; Levonantradol Hydrochloride; Levorphanol Tartrate;Lofemizole Hydrochloride; Lofentanil Oxalate; Lorcinadol; Lomoxicam;Magnesium Salicylate; Mefenamic Acid; Menabitan Hydrochloride;Meperidine Hydrochloride; Meptazinol Hydrochloride; MethadoneHydrochloride; Methadyl Acetate; Methopholine; Methotrimeprazine;Metkephamid Acetate; Mimbane Hydrochloride; Mirfentanil Hydrochloride;Molinazone; Morphine Sulfate; Moxazocine; Nabitan Hydrochloride;Nalbuphine Hydrochloride; Nalmexone Hydrochloride; Namoxyrate; NantradolHydrochloride; Naproxen; Naproxen Sodium; Naproxol; NefopamHydrochloride; Nexeridine Hydrochloride; Noracymethadol Hydrochloride;Ocfentanil Hydrochloride; Octazamide; Olvanil; Oxetorone Fumarate;Oxycodone; Oxycodone Hydrochloride; Oxycodone Terephthalate; OxymorphoneHydrochloride; Pemedolac; Pentamorphone; Pentazocine; PentazocineHydrochloride; Pentazocine Lactate; Phenazopyridine Hydrochloride;Phenyramidol Hydrochloride; Picenadol Hydrochloride; Pinadoline;Pirfenidone; Piroxicam Olamine; Pravadoline Maleate; ProdilidineHydrochloride; Profadol Hydrochloride; Propiram Fumarate; PropoxypheneHydrochloride; Propoxyphene Napsylate; Proxazole; Proxazole Citrate;Proxorphan Tartrate; Pyrroliphene Hydrochloride; RemifentanilHydrochloride; Salcolex; Salethamide Maleate; Salicylamide; SalicylateMeglumine; Salsalate; Sodium Salicylate; Spiradoline Mesylate;Sufentanil; Sufentanil Citrate; Talmetacin; Talniflumate; Talosalate;Tazadolene Succinate; Tebufelone; Tetrydamine; Tifurac Sodium; TilidineHydrochloride; Tiopinac; Tonazocine Mesylate; Tramadol Hydrochloride;Trefentanil Hydrochloride; Trolamine; Veradoline Hydrochloride;Verilopam Hydrochloride; Volazocine; Xorphanol Mesylate; XylazineHydrochloride; Zenazocine Mesylate; Zomepirac Sodium; Zucapsaicin.

[0103] Androgen: Fluoxymesterone; Mesterolone; Methyltestosterone;Nandrolone Decanoate; Nandrolone Phenpropionate; Nisterime Acetate;Oxandrolone; Oxymetholone; Silandrone; Stanozolol; Testosterone;Testosterone Cypionate; Testosterone Enanthate; TestosteroneKetolaurate; Testosterone Phenylacetate; Testosterone Propionate;Trestolone Acetate.

[0104] Anesthesia, adjunct to: Sodium Oxybate.

[0105] Anesthetic: Aliflurane; Benoxinate Hydrochloride; Benzocaine;Biphenamine Hydrochloride; Bupivacaine Hydrochloride; Butamben; ButambenPierate; Chloroprocaine Hydrochloride; Cocaine; Cocaine Hydrochloride;Cyclopropane; Desflurane; Dexivacaine; Diamocaine Cyclamate; Dibucaine;Dibucaine Hydrochloride; Dyclonine Hydrochloride; Enflurane; Ether;Ethyl Chloride; Etidocaine; Etoxadrol Hydrochloride; EuprocinHydrochloride; Fluroxene; Halothane; Isobutamben; Isoflurane; KetamineHydrochloride; Levoxadrol Hydrochloride; Lidocaine; LidocaineHydrochloride; Mepivacaine Hydrochloride; Methohexital Sodium;Methoxyflurane; Midazolam Hydrochloride; Midazolam Maleate; Minaxolone;Nitrous Oxide; Norflurane; Octodrine; Oxethazaine; PhencyclidineHydrochloride; Pramoxine Hydrochloride; Prilocaine Hydrochloride;Procaine Hydrochloride; Propanidid; Proparacaine Hydrochloride;Propofol; Propoxycaine Hydrochloride; Pyrrocaine; Risocaine; Rodocaine;Roflurane; Salicyl Alcohol; Sevoflurane; Teflurane; Tetracaine;Tetracaine Hydrochloride; Thiamylal; Thiamylal Sodium; ThiopentalSodium; Tiletamine Hydrochloride; Zolamine Hydrochloride.

[0106] Anorectic compounds including dexfenfluramine.

[0107] Anorexic: Aminorex; Amphecloral; Chlorphentermine Hydrochloride;Clominorex; Clortermine Hydrochloride; Diethylpropion Hydrochloride;Fenfluramine Hydrochloride; Fenisorex; Fludorex; Fluminorex;Levamfetamine Succinate; Mazindol; Mefenorex Hydrochloride;Phenmetrazine Hydrochloride; Phentermine; Sibutramine Hydrochloride.

[0108] Antagonist: Atipamezole; Atosiban; Bosentan; Cimetidine;Cimetidine Hydrochloride; Clentiazem Maleate; Detirelix Acetate;Devazepide; Donetidine; Etintidine Hydrochloride; Famotidine;Fenmetozole Hydrochloride; Flumazenil; Icatibant Acetate; Icotidine;Isradipine; Metiamide; Nadide; Nalmefene; Nalmexone Hydrochloride;Naloxone Hydrochloride; Naltrexone; Nilvadipine; Oxilorphan; OxmetidineHydrochloride; Oxmetidine Mesylate; Quadazocine Mesylate; Ranitidine;Ranitidine Bismuth Citrate; Ranitidine Hydrochloride; Sufotidine;Teludipine Hydrochloride; Tiapamil Hydrochloride; Tiotidine; VapiprostHydrochloride; Zaltidine Hydrochloride.

[0109] Anterior pituitary activator: Epimestrol.

[0110] Anterior pituitary suppressant: Danazol.

[0111] Anthelmintic: Albendazole; Anthelmycin; Bromoxanide; BunamidineHydrochloride; Butonate; Cambendazole; Carbantel Lauryl Sulfate;Clioxanide; Closantel; Cyclobendazole; Dichlorvos; DiethylcarbamazineCitrate; Dribendazole; Dymanthine Hydrochloride; Etibendazole;Fenbendazole; Furodazole; Hexylresorcinol; Mebendazole; MorantelTartrate; Niclosamide; Nitramisole Hydrochloride; Nitrodan; OxantelPamoate; Oxfendazole; Oxibendazole; Parbendazole; Piperamide Maleate;Piperazine; Piperazine Citrate; Piperazine Edetate Calcium; Proclonol;Pyrantel Pamoate; Pyrantel Tartrate; Pyrvinium Pamoate; Rafoxanide;Stilbazium Iodide; Tetramisole Hydrochloride; Thiabendazole;Ticarbodine; Tioxidazole; Triclofenol Piperazine; Vincofos; Zilantel.

[0112] Anti-acne: Adapalene; Erythromycin Salnacedin; InocoteroneAcetate.

[0113] Anti-adrenergic: Acebutolol; Alprenolol Hydrochloride; Atenolol;Bretylium Tosylate; Bunolol Hydrochloride; Carteolol Hydrochloride;Celiprolol Hydrochloride; Cetamolol Hydrochloride; CicloprololHydrochloride; Dexpropranolol Hydrochloride; Diacetolol Hydrochloride;Dihydroergotamine Mesylate; Dilevalol Hydrochloride; EsmololHydrochloride; Exaprolol Hydrochloride; Fenspiride Hydrochloride;Flestolol Sulfate; Labetalol Hydrochloride; Levobetaxolol Hydrochloride;Levobunolol Hydrochloride; Metalol Hydrochloride; Metoprolol; MetoprololTartrate; Nadolol; Pamatolol Sulfate; Penbutolol Sulfate; PhentolamineMesylate; Practolol; Propranolol Hydrochloride; Proroxan Hydrochloride;Solypertine Tartrate; Sotalol Hydrochloride; Timolol; Timolol Maleate;Tiprenolol Hydrochloride; Tolamolol; Zolertine Hydrochloride.

[0114] Anti-allergic: Amlexanox; Astemizole; Azelastine Hydrochloride;Eclazolast; Minocromil; Nedocromil; Nedocromil Calcium; NedocromilSodium; Nivimedone Sodium; Pemirolast Potassium; Pentigetide;Pirquinozol; Poisonoak Extract; Probicromil Calcium; Proxicromil;Repirinast; Tetrazolast Meglumine; Thiazinamium Chloride; Tiacrilast;Tiacrilast Sodium; Tiprinast Meglumine; Tixanox.

[0115] Anti-amebic: Berythromycin; Bialamicol Hydrochloride;Chloroquine; Chloroquine Hydrochloride; Chloroquine Phosphate;Clamoxyquin Hydrochloride; Clioquinol; Emetine Hydrochloride;Iodoquinol; Paromomycin Sulfate; Quinfamide; Symetine Hydrochloride;Teclozan; Tetracycline; Tetracycline Hydrochloride.

[0116] Anti-androgen: Benorterone; Cioteronel; Cyproterone Acetate;Delmadinone Acetate; Oxendolone; Topterone; Zanoterone.

[0117] Anti-anemic: Epoetin Alfa; Epoetin Beta; Ferrous Sulfate, Dried;Leucovorin Calcium.

[0118] Anti-anginal: Amlodipine Besylate; Amlodipine Maleate; BetaxololHydrochloride; Bevantolol Hydrochloride; Butoprozine Hydrochloride;Carvedilol; Cinepazet Maleate; Metoprolol Succinate; Molsidomine;Monatepil Maleate; Primidolol; Ranolazine Hydrochloride; Tosifen;Verapamil Hydrochloride.

[0119] Anti-anxiety agent: Adatanserin Hydrochloride; Alpidem;Binospirone Mesylate; Bretazenil; Glemanserin; Ipsapirone Hydrochloride;Mirisetron Maleate; Ocinaplon; Ondansetron Hydrochloride; Panadiplon;Pancopride; Pazinaclone; Serazapine Hydrochloride; Tandospirone Citrate;Zalospirone Hydrochloride.

[0120] Anti-arthritic: Lodelaben.

[0121] Anti-asthmatic: Ablukast; Ablukast Sodium; AzelastineHydrochloride; Bunaprolast; Cinalukast; Cromitrile Sodium; CromolynSodium; Enofelast; Isamoxole; Ketotifen Fumarate; Levcromakalim;Lodoxamide Ethyl; Lodoxamide Tromethamine; Montelukast Sodium;Ontazolast; Oxarbazole; Oxatomide; Piriprost; Piriprost Potassium;Pirolate; Pobilukast Edamine; Quazolast; Repirinast; Ritolukast;Sulukast; Tetrazolast Meglumine; Tiaramide Hydrochloride; TibenelastSodium; Tomelukast; Tranilast; Verlukast; Verofylline; Zarirlukast.

[0122] Anti-atherosclerotic: Mifobate; Timefuronc.

[0123] Antibacterial: Acedapsone; Acetosulfone Sodium; Alamecin;Alexidine; Amdinocillin; Amdinocillin Pivoxil; Amicycline; Amifloxacin;Amifloxacin Mesylate; Amikacin; Amikacin Sulfate; Aminosalicylic acid;Aminosalicylate sodium; Amoxicillin; Amphomycin; Ampicillin; AmpicillinSodium; Apalcillin Sodium; Apramycin; Aspartocin; Astromicin Sulfate;Avilamycin; Avoparcin; Azithromycin; Azlocillin; Azlocillin Sodium;Bacampicillin Hydrochloride; Bacitracin; Bacitracin MethyleneDisalicylate; Bacitracin Zinc; Bambermycins; Benzoylpas Calcium;Berythromycin; Betamicin Sulfate; Biapenem; Biniramycin; BiphenamineHydrochloride; Bispyrithione Magsulfex; Butikacin; Butirosin Sulfate;Capreomycin Sulfate; Carbadox; Carbenicillin Disodium; CarbenicillinIndanyl Sodium; Carbenicillin Phenyl Sodium; Carbenicillin Potassium;Carumonam Sodium; Cefaclor; Cefadroxil; Cefamandole; Cefamandole Nafate;Cefamandole Sodium; Cefaparole; Cefatrizine; Cefazaflur Sodium;Cefazolin; Cefazolin Sodium; Cefbuperazone; Cefdinir; Cefepime; CefepimeHydrochloride; Cefetecol; Cefixime; Cefmenoxime Hydrochloride;Cefinetazole; Cefinetazole Sodium; Cefonicid Monosodium; CefonicidSodium; Cefoperazone Sodium; Ceforanide; Cefotaxime Sodium; Cefotetan;Cefotetan Disodium; Cefotiam Hydrochloride; Cefoxitin; Cefoxitin Sodium;Cefpimizole; Cefpimizole Sodium; Cefpiramide; Cefpiramide Sodium;Cefpirome Sulfate; Cefpodoxime Proxetil; Cefprozil; Cefroxadine;Cefsulodin Sodium; Ceftazidime; Ceftibuten; Ceftizoxime Sodium;Ceftriaxone Sodium; Cefuroxime; Cefuroxime Axetil; Cefuroxime Pivoxetil;Cefuroxime Sodium; Cephacetrile Sodium; Cephalexin; CephalexinHydrochloride; Cephaloglycin; Cephaloridine; Cephalothin Sodium;Cephapirin Sodium; Cephradine; Cetocycline Hydrochloride; Cetophenicol;Chloramphenicol; Chloramphenicol Palmitate; Chloramphenicol PantothenateComplex; Chloramphenicol Sodium Succinate; Chlorhexidine Phosphanilate;Chloroxylenol; Chlortetracycline Bisulfate; ChlortetracyclineHydrochloride; Cinoxacin; Ciprofloxacin; Ciprofloxacin Hydrochloride;Cirolemycin; Clarithromycin; Clinafloxacin Hydrochloride; Clindamycin;Clindamycin Hydrochloride; Clindamycin Palmitate Hydrochloride;Clindamycin Phosphate; Clofazimine; Cloxacillin Benzathine; CloxacillinSodium; Cloxyquin; Colistimethate Sodium; Colistin Sulfate; Coumermycin;Coumermycin Sodium; Cyclacillin; Cycloserine; Dalfopristin; Dapsone;Daptomycin; Demeclocycline; Demeclocycline Hydrochloride; Demecycline;Denofingin; Diaveridine; Dicloxacillin; Dicloxacillin Sodium;Dihydrostreptomycin Sulfate; Dipyrithione; Dirithromycin; Doxycycline;Doxycycline Calcium; Doxycycline Fosfatex; Doxycycline Hyclate; DroxacinSodium; Enoxacin; Epicillin; Epitetracycline Hydrochloride;Erythromycin; Erythromycin Acistrate; Erythromycin Estolate;Erythromycin Ethylsuccinate; Erythromycin Gluceptate; ErythromycinLactobionate; Erythromycin Propionate; Erythromycin Stearate; EthambutolHydrochloride; Ethionamide; Fleroxacin; Floxacillin; Fludalanine;Flumequine; Fosfomycin; Fosfomycin Tromethamine; Fumoxicillin;Furazolium Chloride; Furazolium Tartrate; Fusidate Sodium; Fusidic Acid;Gentamicin Sulfate; Gloximonam; Gramicidin; Haloprogin; Hetacillin;Hetacillin Potassium; Hexedine; Ibafloxacin; Imipenem; Isoconazole;Isepamicin; Isoniazid; Josamycin; Kanamycin Sulfate; Kitasamycin;Levofuraltadone; Levopropylcillin Potassium; Lexithromycin; Lincomycin;Lincomycin Hydrochloride; Lomefloxacin; Lomefloxacin Hydrochloride;Lomefloxacin Mesylate; Loracarbef; Mafenide; Meclocycline; MeclocyclineSulfosalicylate; Megalomicin Potassium Phosphate; Mequidox; Meropenem;Methacycline; Methacycline Hydrochloride; Methenamine; MethenamineHippurate; Methenamine Mandelate; Methicillin Sodium; Metioprim;Metronidazole Hydrochloride; Metronidazole Phosphate; Mezlocillin;Mezlocillin Sodium; Minocycline; Minocycline Hydrochloride; MirincamycinHydrochloride; Monensin; Monensin Sodium; Nafcillin Sodium; NalidixateSodium; Nalidixic Acid; Natamycin; Nebramycin; Neomycin Palmitate;Neomycin Sulfate; Neomycin Undecylenate; Netilmicin Sulfate;Neutramycin; Nifuradene; Nifuraldezone; Nifuratel; Nifuratrone;Nifurdazil; Nifurimide; Nifurpirinol; Nifurquinazol; Nifurthiazole;Nitrocycline; Nitrofurantoin; Nitromide; Norfloxacin; Novobiocin Sodium;Ofloxacin; Ormetoprim; Oxacillin Sodium; Oximonam; Oximonam Sodium;Oxolinic Acid; Oxytetracycline; Oxytetracycline Calcium; OxytetracyclineHydrochloride; Paldimycin; Parachlorophenol; Paulomycin; Pefloxacin;Pefloxacin Mesylate; Penamecillin; Penicillin G Benzathine; Penicillin GPotassium; Penicillin G Procaine; Penicillin G Sodium; Penicillin V;Penicillin V Benzathine; Penicillin V Hydrabamine: Penicillin VPotassium; Pentizidone Sodium; Phenyl Aminosalicylate; PiperacillinSodium; Pirbenicillin Sodium; Piridicillin Sodium; PirlimycinHydrochloride; Pivampicillin Hydrochloride; Pivampicillin Pamoate;Pivampicillin Probenate; Polymyxin B Sulfate; Porfiromycin; Propikacin;Pyrazinamide; Pyrithione Zinc; Quindecamine Acetate; Quinupristin;Racephenicol; Ramoplanin; Ranimycin; Relomycin; Repromicin; Rifabutin;Rifametane; Rifamexil; Rifamide; Rifampin; Rifapentine; Rifaximin;Rolitetracycline; Rolitetracycline Nitrate: Rosaramicin; RosaramicinButyrate; Rosaramicin Propionate; Rosaramicin Sodium Phosphate;Rosaramicin Stearate; Rosoxacin; Roxarsone; Roxithromycin; Sancycline;Sanfetrinem Sodium; Sarmoxicillin; Sarpicillin; Scopafingin; Sisomicin;Sisomicin Sulfate; Spariloxacin; Spectinomycin Hydrochloride;Spiramycin; Stallimycin Hydrochloride; Steffimycin; StreptomycinSulfate; Streptonicozid; Sulfabenz; Sulfabenzamide; Sulfacetamide;Sulfacetamide Sodium; Sulfacytine; Sulfadiazine; Sulfadiazine Sodium;Sulfadoxine; Sulfalene; Sulfamerazine; Sulfameter; Sulfamethazine;Sulfamethizole; Sulfamethoxazole; Sulfamonomethoxine; Sulfamoxole;Sulfanilate Zinc; Sulfanitran; Sulfasalazine; Sulfasomizole;Sulfathiazole; Sulfazamet; Sulfisoxazole; Sulfisoxazole Acetyl;Sulfisoxazole Diolamine; Sulfomyxin; Sulopenem; Sultamicillin; SuncillinSodium; Talampicillin Hydrochloride; Teicoplanin; TemafloxacinHydrochloride; Temocillin; Tetracycline; Tetracycline Hydrochloride;Tetracycline Phosphate Complex; Tetroxoprim; Thiamphenicol;Thiphencillin Potassium; Ticarcillin Cresyl Sodium; TicarcillinDisodium; Ticarcillin Monosodium; Ticlatone; Tiodonium Chloride;Tobramycin; Tobramycin Sulfate; Tosufloxacin; Trimethoprim; TrimethoprimSulfate; Trisulfapyrimidines; Troleandomycin; Trospectomycin Sulfate;Tyrothricin: Vancomycin; Vancomycin Hydrochloride; Virginiamycin;Zorbamycin.

[0124] Anticholelithic: Monoctanoin.

[0125] Anticholelithogenic: Chenodiol; Ursodiol.

[0126] Anticholinergic: Alverinc Citrate; Anisotropine Methylbromide;Atropine; Atropine Oxide Hydrochloride; Atropine Sulfate; Belladonna;Benapryzine Hydrochloride; Benzetimide Hydrochloride; BenziloniumBromide; Biperiden; Biperiden Hydrochloride; Biperiden Lactate;Clidinium Bromide; Cyclopentolate Hydrochloride; Dexetimide; DicyclomineHydrochloride; Dihexyverine Hydrochloride: Domazoline Fumarate;Elantrine; Elucaine; Ethybenztropine; Eucatropine Hydrochloride:Glycopyrrolate; Heteronium Bromide; Homatropine Hydrobromide;Homatropine Methylbromide; Hyoscyamine; Hyoscyamine Hydrobromide;Hyoscyamine Sulfate; Isopropamide Iodide; Mepenzolate Bromide;Methylatropine Nitrate; Metoquizine; Oxybutynin Chloride; ParapenzolateBromide; Pentapiperium Methylsulfate; Phencarbamide; PoldineMethylsulfate; Proglumide; Propantheline Bromide; PropenzolateHydrochloride; Scopolamine Hydrobromide; Tematropium Methylsulfate;Tiquinamide Hydrochloride; Tofenacin Hydrochloride; Toquizine;Triampyzine Sulfate; Trihexyphenidyl Hydrochloride; Tropicamide.

[0127] Anticoagulant: Ancrod; Anticoagulant Citrate Dextrose Solution;Anticoagulant Citrate Phosphate Dextrose Adenine Solution; AnticoagulantCitrate Phosphate Dextrose Solution; Anticoagulant Heparin Solution;Anticoagulant Sodium Citrate Solution; Ardeparin Sodium; Bivalirudin;Bromindione; Dalteparin Sodium; Desirudin; Dicumarol; Heparin Calcium;Heparin Sodium; Lyapolate Sodium; Nafamostat Mesylate; Phenprocoumon;Tinzaparin Sodium; Warfarin Sodium.

[0128] Anticoccidal: Maduramicin.

[0129] Anticonvulsant: Albutoin; Ameltolide; Atolide; Buramate;Carbamazepine; Cinromide; Citenamide; Clonazepam; Cyheptamide;Dezinamide; Dimethadione; Divalproex Sodium; Eterobarb; Ethosuximide;Ethotoin; Flurazepam Hydrochloride; Fluzinamide; Fosphenytoin Sodium;Gabapentin; Ilepcimide; Lamotrigine; Magnesium Sulfate; Mephenytoin;Mephobarbital; Methetoin; Methsuximide: Milacemide Hydrochloride;Nabazenil; Nafimidone Hydrochloride; Nitrazepain; Phenacemide;Phenobarbital; Phenobarbital Sodium; Phensuximide; Phenytoin; PhenytoinSodium; Primidone; Progabide; Ralitoline; Remacemide Hydrochloride;Ropizine; Sabeluzole; Stiripentol; Sulthiame; Thiopental Sodium;Tiletamine Hydrochloride; Topiramate; Trimethadione: Valproate Sodium;Valproic Acid; Vigabatrin; Zoniclezole Hydrochloride; Zonisamide.

[0130] Antidepressant: Adatanserin Hydrochloride: Adinazolam; AdinazolamMesylate; Alaproclate; Aletamine Hydrochloride; Amedalin Hydrochloride;Amitriptyline Hydrochloride; Amoxapine; Aptazapine Maleate; AzaloxanFumarate; Azepindole; Azipramine Hydrochloride; Bipenamol Hydrochloride;Bupropion Hydrochloride; Butacetin; Butriptyline Hydrochloride;Caroxazone; Cartazolate; Ciclazindol; Cidoxepin Hydrochloride;Cilobamine Mesylate; Clodazon Hydrochloride; Clomipramine Hydrochloride;Cotinine Fumarate; Cyclindole; Cypenamine Hydrochloride; CyprolidolHydrochloride; Cyproximide; Daledalin Tosylate; DapoxetineHydrochloride; Dazadrol Maleate; Dazepinil Hydrochloride; DesipramineHydrochloride; Dexamisole; Deximafen; Dibenzepin Hydrochloride;Dioxadrol Hydrochloride; Dothiepin Hydrochloride; Doxepin Hydrochloride;Duloxetine Hydrochloride; Eclanamine Maleate; Encyprate; EtoperidoneHydrochloride; Fantridone Hydrochloride; Fenmetozole Hydrochloride;Fenmetramide; Fezolamine Fumarate; Fluotracen Hydrochloride; Fluoxetine;Fluoxetine Hydrochloride; Fluparoxan Hydrochloride; Gamfexine;Guanoxyfen Sulfate; Imafen Hydrochloride; Imiloxan Hydrochloride;Imipramine Hydrochloride; Indeloxazine Hydrochloride; IntriptylineHydrochloride; Iprindole; Isocarboxazid; Ketipramine Fumarate;Lofepramine Hydrochloride; Lortalamine; Maprotiline; MaprotilineHydrochloride; Melitracen Hydrochloride; Milacemide Hydrochloride:Minaprine Hydrochloride; Mirtazapine; Moclobemide; Modaline Sulfate;Napactadine Hydrochloride; Napamezole Hydrochloride; NefazodoneHydrochloride; Nisoxetine; Nitrafudam Hydrochloride; NomifensineMaleate; Nortriptyline Hydrochloride; Octriptyline Phosphate; OpipramolHydrochloride; Oxaprotiline Hydrochloride; Oxypertine; Paroxetine;Phenelzine Sulfate; Pirandamine Hydrochloride; Pizotyline; PridefineHydrochloride; Prolintane Hydrochloride; Protriptyline Hydrochloride;Quipazine Maleate; Rolicyprine; Seproxetine Hydrochloride; SertralineHydrochloride; Sibutramine Hydrochloride; Sulpiride; Suritozole;Tametraline Hydrochloride; Tampramine Fumarate; Tandamine Hydrochloride;Thiazesim Hydrochloride; Thozalinone; Tomoxetine Hydrochloride;Trazodone Hydrochloride; Trebenzomine Hydrochloride; Trimipramine;Trimipramine Maleate; Venlafaxine Hydrochloride; ViloxazineHydrochloride; Zimeldine Hydrochloride; Zometapine.

[0131] Antidiabetic: Acetohexamide; Buformin; Butoxamine Hydrochloride;Camiglibose; Chlorpropamide; Ciglitazone; Englitazone Sodium; EtoforminHydrochloride; Gliamilide; Glibomuride; Glicetanile Sodium; Gliflumide;Glipizide; Glucagon; Glyburide; Glyhexamide; Glymidine Sodium;Glyoctamide; Glyparamide; Insulin; Insulin, Dalanated; Insulin Human;Insulin Human, Isophane; Insulin Human Zinc; Insulin Human Zinc,Extended; Insulin, Isophane; Insulin Lispro; Insulin, Neutral; InsulinZinc; Insulin Zinc, Extended; Insulin Zinc, Prompt; Linogliride;Linogliride Fumarate; Metformin; Methyl Palmoxirate; Palmoxirate Sodium;Pioglitazone Hydrochloride; Pirogliride Tartrate; Proinsulin Human;Seglitide Acetate; Tolazamide; Tolbutamide; Tolpyrramide; Troglitazone;Zopolrestat.

[0132] Antidiarrheal: Rolgamidine, Diphenoxylate hydrochloride(Lomotil), Metronidazole (Flagyl), Methylprednisolone (Medrol),Sulfasalazine (Azulfidine).

[0133] Antidiuretic: Argipressin Tannate; Desmopressin Acetate;Lypressin.

[0134] Antidote: Dimercaprol; Edrophonium Chloride; Fomepizole;Leucovorin Calcium; Levoleucovorin Calcium; Methylene Blue; ProtamineSulfate.

[0135] Antidyskinetic: Selegiline Hydrochloride.

[0136] Anti-emetic: Alosetron Hydrochloride; Batanopride Hydrochloride;Bemesetron; Benzquinamide; Chlorpromazine; Chlorpromazine Hydrochloride;Clebopride; Cyclizine Hydrochloride; Dimenhydrinate; Diphenidol;Diphenidol Hydrochloride; Diphenidol Pamoate; Dolasetron Mesylate;Domperidone; Dronabinol; Fludorex; Flumeridone; GaldansetronHydrochloride; Granisetron; Granisetron Hydrochloride; LurosetronMesylate; Meclizine Hydrochloride; Metoclopramide Hydrochloride;Metopimazine; Ondansetron Hydrochloride; Pancopride; Prochlorperazine;Prochlorperazine Edisylate; Prochlorperazine Maleate; PromethazineHydrochloride; Thiethylperazine; Thiethylperazine Malate;Thiethylperazine Maleate; Trimethobenzamide Hydrochloride; ZacoprideHydrochloride.

[0137] Anti-epileptic: Felbamate; Loreclezole; Tolgabide.

[0138] Anti-estrogen: Clometherone; Delmadinone Acetate; NafoxidineHydrochloride; Nitromifene Citrate; Raloxifene Hydrochloride; TamoxifenCitrate; Toremifene Citrate; Trioxifene Mesylate.

[0139] Antifibrinolytic: Nafamostat Mesylate.

[0140] Antifungal: Acrisorcin; Ambruticin; Amphotericin B; Azaconazole;Azaserine; Basifungin; Bifonazole; Biphenamine Hydrochloride;Bispyrithione Magsulfex; Butoconazole Nitrate; Calcium Undecylenate;Candicidin; Carbol-Fuchsin; Chlordantoin; Ciclopirox; CiclopiroxOlamine; Cilofungin; Cisconazole; Clotrimazole; Cuprimyxin; Denofungin;Dipyrithione; Doconazole; Econazole; Econazole Nitrate; Enilconazole;Ethonam Nitrate; Fenticonazole Nitrate; Filipin; Fluconazole;Flucytosine; Fungimycin; Griseofulvin; Hamycin; Isoconazole;Itraconazole; Kalafungin; Ketoconazole; Lomofungin; Lydimycin;Mepartricin; Miconazole; Miconazole Nitrate; Monensin; Monensin Sodium;Naftifine Hydrochloride; Neomycin Undecylenate; Nifuratel; Nifurmerone;Nitralamine Hydrochloride; Nystatin; Octanoic Acid; Orconazole Nitrate;Oxiconazole Nitrate; Oxifungin Hydrochloride; Parconazole Hydrochloride;Partricin; Potassium Iodide; Proclonol; Pyrithione Zinc; Pyrrolnitrin;Rutamycin; Sanguinarium Chloride; Saperconazole: Scopafungin; SeleniumSulfide; Sinefingin; Sulconazole Nitrate; Terbinafine; Terconazole;Thiram; Ticlatone; Tioconazole; Tolciclate; Tolindate; Tolnaftate;Triacetin; Triafungin; Undecylenic Acid; Viridofulvin; ZincUndecylenate; Zinoconazole Hydrochloride.

[0141] Antiglaucoma agent: Alprenoxime Hydrochloride; Colforsin;Dapiprazole Hydrochloride; Dipivefrin Hydrochloride; Naboctate Hydrochloride; Pilocarpine; Pimabine.

[0142] Antihemophilic: Antihemophilic Factor.

[0143] Antihemorrhagic: Poliglusam.

[0144] Antihistaminic: Acrivastine; Antazoline Phosphate; Astemizole;Azatadine Maleate; Barmastine; Bromodiphenhydramine Hvdrochloride;Brompheniramine Maleate; Carbinoxamine Maleate; CetirizineHydrochloride; Chlorpheniramine Maleate; Chlorpheniramine Polistirex;Cinnarizine; Clemastine; Clemastine Fumarate; Closiramine Aceturate;Cycliramine Maleate; Cyclizine; Cyproheptadine Hydrochloride;Dexbrompheniramine Maleate; Dexchlorpheniramine Maleate; DimethindeneMaleate; Diphenhydramine Citrate; Diphenhydramine Hydrochloride;Dorastine Hydrochloride; Doxylamine Succinate; Ebastine; LevocabastineHydrochloride; Loratadine; Mianserin Hydrochloride; Noberastine;Orphenadrine Citrate; Pyrabrom; Pyrilamine Maleate; Pyroxamine Maleate;Rocastine Hydrochloride; Rotoxamine; Tazifylline Hydrochloride;Temelastine; Terfenadine; Tripelennamine Citrate; TripelennamineHydrochloride; Triprolidine Hydrochloride; Zolamine Hydrochloride.

[0145] Antihyperlipidemic: Cholestyramine Resin; Clofibrate; ColestipolHydrochloride; Crilvastatin; Dalvastatin; Dextrothyroxine Sodium;Fluvastatin Sodium; Gemfibrozil; Lecimibide; Lovastatin; Niacin;Pravastatin Sodium; Probucol; Simvastatin; Tiqueside; Xenbucin.

[0146] Antihyperlipoproteinemic: Acifran; Beloxamide; Bezafibrate;Boxidine; Butoxamine Hydrochloride; Cetaben Sodium; Ciprofibrate;Gemcadiol; Halofenate; Lifibrate; Meglutol; Nafenopin; PimetineHydrochloride; Theofibrate; Tibric Acid; Treloxinate.

[0147] Antihypertensive: Alfuzosin Hydrochloride; Alipamide; Althiazide;Amiquinsin Hydrochloride; Amlodipine Besylate; Amlodipine Maleate;Anaritide Acetate; Atiprosin Maleate; Belfosdil; Bemitradine; BendacalolMesylate; Bendroflumethiazide; Benzthiazide; Betaxolol Hydrochloride;Bethanidine Sulfate; Bevantolol Hydrochloride; Biclodil Hydrochloride;Bisoprolol; Bisoprolol Fumarate; Bucindolol Hydrochloride; Bupicomide;Buthiazide: Candoxatril; Candoxatrilat; Captopril; Carvedilol;Ceronapril; Chlorothiazide Sodium; Cicletanine; Cilazapril; Clonidine;Clonidine Hydrochloride; Clopamide; Cyclopenthiazide; Cyclothiazide;Darodipine; Debrisoquin Sulfate; Delapril Hydrochloride; Diapamide;Diazoxide; Dilevalol Hydrochloride; Diltiazem Malate; Ditekiren;Doxazosin Mesylate; Ecadotril; Enalapril Maleate; Enalaprilat;Enalkiren; Endralazine Mesylate; Epithiazide; Eprosartan; EprosartanMesylate; Fenoldopam Mesylate; Flavodilol Maleate; Flordipine;Flosequinan; Fosinopril Sodium; Fosinoprilat; Guanabenz; GuanabenzAcetate; Guanacline Sulfate; Guanadrel Sulfate; Guancydine; GuanethidineMonosulfate; Guanethidine Sulfate; Guanfacine Hydrochloride; GuanisoquinSulfate; Guanoclor Sulfate; Guanoctine Hydrochloride; Guanoxabenz;Guanoxan Sulfate; Guanoxyfen Sulfate; Hydralazine Hydrochloride;Hydralazine Polistirex; Hydroflumethiazide; Indacrinone; Indapamide;Indolapril Hydrochloride; Indoramin; Indoramin Hydrochloride; IndorenateHydrochloride; Lacidipine; Leniquinsin; Levcromakalim; Lisinopril;Lofexidine Hydrochloride; Losartan Potassium; Losulazine Hydrochloride;Mebutamate; Mecamylamine Hydrochloride; Medroxalol; MedroxalolHydrochloride; Methalthiazide; Methyclothiazide; Methyldopa;Methyldopate Hydrochloride; Metipranolol; Metolazone; MetoprololFumarate; Metoprolol Succinate; Metyrosine; Minoxidil; MonatepilMaleate; Muzolimine; Nebivolol; Nitrendipine; Ofornine; PargylineHydrochloride; Pazoxide; Pelanserin Hydrochloride; Perindopril Erbumine;Phenoxybenzamine Hydrochloride; Pinacidil; Pivopril; Polythiazide;Prazosin Hydrochloride; Primidolol; Prizidilol Hydrochloride; QuinaprilHydrochloride; Quinaprilat; Quinazosin Hydrochloride; QuineloraneHydrochloride; Quinpirole Hydrochloride: Quinuclium Bromide; Ramipril;Rauwolfia Serpentina; Reserpine; Saprisartan Potassium; SaralasinAcetate; Sodium Nitroprusside; Sulfinalol Hydrochloride; Tasosartan;Teludipine Hydrochloride; Temocapril Hydrochloride; TerazosinHydrochloride; Terlakiren; Tiamenidine; Tiamenidine Hydrochloride;Ticrynafen; Tinabinol; Tiodazosin; Tipentosin Hydrochloride;Trichlormethiazide; Trimazosin Hydrochloride; Trimethaphan Camsylate;Trimoxamine Hydrochloride; Tripamide; Xipamide; Zankiren Hydrochloride;Zofenoprilat Arginine.

[0148] Antihypotensive: Ciclafrine Hydrochloride- MidodrineHydrochloride.

[0149] Anti-infective: Difloxacin Hydrochloride; Lauryl IsoquinoliniumBromide; Moxalactam Disodium; Ornidazole; Pentisomicin; SarafloxacinHydrochloride; Protease inhibitors of HIV and other retroviruses;Integrase Inhibitors of HIV and other retroviruses; Cefaclor (Ceclor);Acyclovir (Zovirax); Norfloxacin (Noroxin); Cefoxitin (Mefoxin);Cefuroxime axetil (Ceftin); Ciprofloxacin (Cipro).

[0150] Anti-infective, topical: Alcohol; Aminacrine Hydrochloride;Benzethonium Chloride: Bithionolate Sodium; Bromchlorenone; CarbamidePeroxide; Cetalkonium Chloride; Cetylpyridinium Chloride: ChlorhexidineHydrochloride; Clioquinol; Domiphen Bromide; Fenticlor; FludazoniumChloride; Fuchsin. Basic; Furazolidone; Gentian Violet; Halquinols;Hexachlorophene: Hydrogen Peroxide; Ichthammol; Imidecyl Iodine; Iodine;Isopropyl Alcohol; Mafenide Acetate; Meralein Sodium; MercufenolChloride; Mercury, Ammoniated; Methylbenzethonium Chloride;Nitrofurazone; Nitromersol; Octenidine Hydrochloride; Oxychlorosene;Oxychlorosene Sodium; Parachlorophenol, Camphorated; PotassiumPermanganate; Povidone-Iodine; Sepazonium Chloride; Silver Nitrate;Sulfadiazine, Silver; Symclosene; Thimerfonate Sodium; Thimerosal:Troclosene Potassium.

[0151] Anti-inflammatory: Alclofenac; Alclometasone Dipropionate;Algestone Acetonide; Alpha Amylase; Amcinafal; Amcinafide; AmfenacSodium; Amiprilose Hydrochloride; Anakinra; Anirolac; Anitrazafen;Apazone; Balsalazide Disodium; Bendazac; Benoxaprofen; BenzydamineHydrochloride; Bromelains; Broperamole; Budesonide; Carprofen;Cicloprofen; Cintazone; Cliprofen; Clobetasol Propionate; ClobetasoneButyrate; Clopirac; Cloticasone Propionate; Cormethasone Acetate;Cortodoxone; Deflazacort; Desonide; Desoximetasone; DexamethasoneDipropionate; Diclofenac Potassium; Diclofenac Sodium; DiflorasoneDiacetate; Diflumidone Sodium; Diflunisal; Difluprednate; Diftalone;Dimethyl Sulfoxide; Drocinonide; Endrysone; Enlimomab; Enolicam Sodium;Epirizole; Etodolac; Etofenamate; Felbinac; Fenamole; Fenbufen;Fenclofenac; Fenclorac; Fendosal; Fenpipalone; Fentiazac; Flazalone;Fluazacort; Flufenamic Acid; Flumizole; Flunisolide Acetate; Flunixin;Flunixin Meglumine; Fluocortin Butyl; Fluorometholone Acetate;Fluquazone; Flurbiprofen; Fluretofen; Fluticasone Propionate;Furaprofen; Furobufen; Halcinonide; Halobetasol Propionate; HalopredoneAcetate; Ibufenac; Ibuprofen; Ibuprofen Aluminum; Ibuprofen Piconol;Ilonidap; Indomethacin; Indomethacin Sodium; Indoprofen; Indoxole;Intrazole; Isoflupredone Acetate; Isoxepac; Isoxicam; Ketoprofen;Lofemizole Hydrochloride; Lornoxicam; Loteprednol Etabonate;Meclofenamate Sodium; Meclofenamic Acid; Meclorisone Dibutyrate;Mefenamic Acid; Mesalamine; Meseclazone; Methylprednisolone Suleptanate;Morniflumate; Nabumetone; Naproxen; Naproxen Sodium; Naproxol; Nimazone;Olsalazine Sodium; Orgotein; Orpanoxin; Oxaprozin; Oxyphenbutazone;Paranyline Hydrochloride; Pentosan Polysulfate Sodium; PhenbutazoneSodium Glycerate; Pirfenidone; Piroxicam; Piroxicam Cinnamate; PiroxicamOlamine; Pirprofen; Prednazate; Prifelone; Prodolic Acid; Proquazone;Proxazole; Proxazole Citrate; Rimexolone; Romazarit; Salcolex;Salnacedin; Salsalate; Sanguinarium Chloride; Seclazone; Sermetacin;Sudoxicam; Sulindac; Suprofen; Talmetacin; Talniflumate; Talosalate;Tebufelone; Tenidap; Tenidap Sodium; Tenoxicam; Tesicarn; Tesimide;Tetrydamine; Tiopinac; Tixocortol Pivalate; Tolmetin; Tolmetin Sodium;Triclonide; Triflumidate; Zidometacin; Zomepirac Sodium.

[0152] Antikeratinizing agent: Doretinel; Linarotene; Pelretin.

[0153] Antimalarial: Acedapsone; Amodiaquine Hydrochloride; Amquinate;Arteflene; Chloroquine; Chloroquine Hydrochloride; ChloroquinePhosphate; Cycloguanil Pamoate; Enpiroline Phosphate; HalofantrineHydrochloride; Hydroxychloroquine Sulfate; Mefloquine Hydrochloride;Menoctone; Mirincamycin Hydrochloride; Primaquine Phosphate;Pyrimethamine; Quinine Sulfate; Tebuquine.

[0154] Antimicrobial: Aztreonam; Chlorhexidine Gluconate; Imidurea;Lycetamine; Nibroxane; Pirazmonam Sodium; Propionic Acid; PyrithioneSodium; Sanguinarium Chloride; Tigemonam Dicholine.

[0155] Antimigraine: Dolasetron Mesylate; Naratriptan Hydrochloride;Sergolexole Maleate; Sumatriptan Succinate; Zatosetron Maleate.

[0156] Antimitotic: Podofilox.

[0157] Antimycotic: Amorolfine.

[0158] Antinauseant: Buclizine Hydrochloride; Cyclizine Lactate;Naboctate Hydrochloride.

[0159] Antineoplastic: Acivicin; Aclarubicin; Acodazole Hydrochloride;Acronine; Adozelesin; Aldesleukin; Altretamine; Ambomycin; AmetantroneAcetate; Aminoglutethimide; Amsacrine; Anastrozole; Anthramycin;Asparaginase; Asperlin; Azacitidine; Azetepa; Azotomycin; Batimastat;Benzodepa; Bicalutamide; Bisantrene Hydrochloride; Bisnafide Dimesylate;Bizelesin; Bleomycin Sulfate; Brequinar Sodium; Bropirimine; Busulfan;Cactinomycin; Calusterone; Caracemide; Carbetimer; Carboplatin;Carmustine; Carubicin Hydrochloride; Carzelesin; Cedefingol;Chlorambucil; Cirolemycin; Cisplatin; Cladribine; Crisnatol Mesylate;Cyclophosphamide; Cytarabine; Dacarbazine; Dactinomycin; DaunorubicinHydrochloride; Decitabine; Dexormaplatin; Dezaguanine; DezaguanineMesylate; Diaziquone; Docetaxel; Doxorubicin; Doxorubicin Hydrochloride;Droloxifene; Droloxifene Citrate; Dromostanolone Propionate; Duazomycin;Edatrexate; Eflomithine Hydrochloride; Elsamitrucin; Enloplatin;Enpromate; Epipropidine; Epirubicin Hydrochloride; Erbulozole;Esorubicin Hydrochloride; Estramustine; Estramustine Phosphate Sodium;Etanidazole; Ethiodized Oil I 131; Etoposide; Etoposide Phosphate;Etoprine; Fadrozole Hydrochloride; Fazarabine; Fenretinide; Floxuridine;Fludarabine Phosphate; Fluorouracil; Flurocitabine; Fosquidone;Fostriecin Sodium; Gemcitabine; Gemcitabine Hydrochloride; Gold Au 198;Hydroxyurea; Idarubicin Hydrochloride; Ifosfamide; Ilmofosine;Interferon Alfa-2a; Interferon Alfa-2b; Interferon Alfa-n1; InterferonAlfa-n3; Interferon Beta- I a; Interferon Gamma- I b; Iproplatin;Irinotecan Hydrochloride; Lanreotide Acetate; Letrozole; LeuprolideAcetate; Liarozole Hydrochloride; Lometrexol Sodium; Lomustine;Losoxantrone Hydrochloride; Masoprocol; Maytansine; MechlorethamineHydrochloride; Megestrol Acetate; Melengestrol Acetate; Melphalan;Menogaril; Mercaptopurine; Methotrexate; Methotrexate Sodium; Metoprine;Meturedepa; Mitindomide; Mitocarcin; Mitocromin; Mitogillin; Mitomalcin;Mitomycin; Mitosper; Mitotane; Mitoxantrone Hydrochloride; MycophenolicAcid; Nocodazole; Nogalamycin; Ormaplatin; Oxisuran; Paclitaxel;Pegaspargase; Peliomycin; Pentamustine; Peplomycin Sulfate;Perfosfamide; Pipobroman; Piposulfan; Piroxantrone Hydrochloride;Plicamycin; Plomestane; Porfimer Sodium; Porfiromycin; Prednimustine;Procarbazine Hydrochloride; Puromycin; Puromycin Hydrochloride;Pyrazofurin; Riboprine; Rogletimide; Safingol; Safingol Hydrochloride;Semustine; Simtrazene; Sparfosate Sodium; Sparsomycin; SpirogermaniumHydrochloride; Spiromustine; Spiroplatin; Streptonigrin; Streptozocin;Strontium Chloride Sr 89; Sulofenur; Talisomycin; Taxane; Taxoid;Tecogalan Sodium; Tegafur; Teloxantrone Hydrochloride; Temoporfin;Teniposide; Teroxirone; Testolactone; Thiamiprine; Thioguanine;Thiotepa; Tiazofurin; Tirapazamine; Topotecan Hydrochloride; ToremifeneCitrate; Trestolone Acetate; Triciribine Phosphate; Trimetrexate;Trimetrexate Glucuronate; Triptorelin; Tubulozole Hydrochloride; UracilMustard; Uredepa; Vapreotide; Verteporfin; Vinblastine Sulfate;Vincristine Sulfate; Vindesine; Vindesine Sulfate; Vinepidine Sulfate;Vinglycinate Sulfate; Vinleurosine Sulfate; Vinorelbine Tartrate;Vinrosidine Sulfate; Vinzolidine Sulfate; Vorozole; Zeniplatin;Zinostatin; Zorubicin Hydrochloride.

[0160] Other anti-neoplastic compounds include: 20-epi-1,25dihydroxyvitamin D3; 5-ethynyluracil; abiraterone; aclarubicin;acylfulvene; adecypenol; adozelesin; aldesleukin; ALL-TK antagonists;altretamine; ambamustine; amidox; amifostine; aminolevulinic acid;amrubicin; amsacrine; anagrelide; anastrozole; andrographolide;angiogenesis inhibitors; antagonist D; antagonist G; antarelix;anti-dorsalizing morphogenetic protein-1; antiandrogen, prostaticcarcinoma; antiestrogen; antineoplaston; antisense oligonucleotides;aphidicolin glycinate; apoptosis gene modulators; apoptosis regulators;apurinic acid; ara-CDP-DL-PTBA; arginine deaminase; asulacrine;atamestane; atrimustine; axinastatin 1; axinastatin 2; axinastatin 3;azasetron; azatoxin; azatyrosine; baccatin III derivatives; balanol;batimastat; BCR/ABL antagonists; benzochlorins; benzoylstaurosporine;beta lactam derivatives; beta-alethine; betaclamycin B; betulinic acid;bFGF inhibitor; bicalutamide; bisantrene; bisaziridinylspermine;bisnafide; bistratene A; bizelesin; breflate; bropirimine; budotitane;buthionine sulfoximine; calcipotriol; calphostin C; camptothecinderivatives; canarypox IL-2; capecitabine; carboxamide-amino-triazole;carboxyamidotriazole; CaRest M3; CARN 700; cartilage derived inhibitor;carzelesin; casein kinase inhibitors (ICOS); castanospermine; cecropinB; cetrorelix; chlorins; chloroquinoxaline sulfonamide; cicaprost;cis-porphyrin; cladribine; clomifene analogues; clotrimazole;collismycin A; collismycin B; combretastatin A4; combretastatinanalogue; conagenin; crambescidin 816; crisnatol; cryptophycin 8;cryptophycin A derivatives; curacin A; cyclopentanthraquinones;cycloplatam; cypemycin; cytarabine ocfosfate; cytolytic factor;cytostatin; dacliximab; decitabine; dehydrodidemnin B; deslorelin;dexifosfamide; dexrazoxane; dexverapamil; diaziquone; didemnin B; didox;diethylnorspermine; dihydro-5-azacytidine; dihydrotaxol, 9-; dioxamycin;diphenyl spiromustine; docosanol; dolasetron; doxifluridine;droloxifene; dronabinol; duocarmycin SA; ebselen; ecomustine;edelfosine; edrecolomab; eflornithine; elemene; emitefur; epirubicin;epristeride; estramustine analogue; estrogen agonists; estrogenantagonists; etanidazole; etoposide phosphate; exemestane; fadrozole;fazarabine; fenretinide; filgrastim; finasteride; flavopiridol;flezelastine; fluasterone; fludarabine; fluorodaunorunicinhydrochloride; forfenimex; formestane; fostriecin; fotemustine;gadolinium texaphyrin; gallium nitrate; galocitabine; ganirelix;gelatinase inhibitors; gemcitabine; glutathione inhibitors; hepsulfam;heregulin; hexamethylene bisacetamide; hypericin; ibandronic acid;idarubicin; idoxifene; idramantone; ilmofosine; ilomastat;imidazoacridones; imiquimod; immunostimulant peptides; insulin-likegrowth factor-1 receptor inhibitor; interferon agonists; interferons;interleukins; iobenguane; iododoxorubicin; ipomeanol, 4-; irinotecan;iroplact; irsogladine; isobengazole; isohomohalicondrin B; itasetron;jasplakinolide; kahalalide F; lamellarin-N triacetate; lanreotide;leinamycin; lenograstim; lentinan sulfate; leptolstatin; letrozole;leukemia inhibiting factor; leukocyte alpha interferon;leuprolide+estrogen+progesterone; leuprorelin; levamisole; liarozole;linear polyamine analogue; lipophilic disaccharide peptide; lipophilicplatinum compounds; lissoclinamide 7; lobaplatin; lombricine;lometrexol; lonidamine; losoxantrone; lovastatin; loxoribine;lurtotecan; lutetium texaphyrin; lysofylline; lytic peptides;maitansine; mannostatin A; marimastat; masoprocol; maspin; matrilysininhibitors; matrix metalloproteinase inhibitors; menogaril; merbarone;meterelin; methioninase; metoclopramide; MIF inhibitor; mifepristone;miltefosine; mirimostim; mismatched double stranded RNA; mitoguazone;mitolactol; mitomycin analogues; mitonafide; mitotoxin fibroblast growthfactor-saporin; mitoxantrone; mofarotene; molgramostim; monoclonalantibody, human chorionic gonadotrophin; monophosphoryl lipid A+myobacterium cell wall sk; mopidamol; multiple drug resistance geneinhibitor; multiple tumor suppressor 1-based therapy; mustard anticanceragent; mycaperoxide B; mycobacterial cell wall extract; myriaporone;N-acetyldinaline; N-substituted benzamides; nafarelin; nagrestip;naloxone +pentazocine; napavin; naphterpin; nartograstim; nedaplatin;nemorubicin; neridronic acid; neutral endopeptidase; nilutamide;nisamycin; nitric oxide modulators; nitroxide antioxidant; nitrullyn;O6-benzylguanine; octreotide; okicenone; oligonucleotides; onapristone;ondansetron; ondansetron; oracin; oral cytokine inducer; ormaplatin;osaterone; oxaliplatin; oxaunomycin; paclitaxel analogues; paclitaxelderivatives; palauamine; palmitoylrhizoxin; pamidronic acid;panaxytriol; panomifene; parabactin; pazelliptine; pegaspargase;peldesine; pentosan polysulfate sodium; pentostatin; pentrozole;perflubron; perfosfamide; perillyl alcohol; phenazinomycin;phenylacetate; phosphatase inhibitors; picibanil; pilocarpinehydrochloride; pirarubicin; piritrexim; placetin A; placetin B;plasminogen activator inhibitor; platinum complex; platinum compounds;platinum-triamine complex; porfimer sodium; porfiromycin; propylbis-acridone; prostaglandin J2; proteasome inhibitors; protein A-basedimmune modulator; protein kinase C inhibitor; protein kinase Cinhibitors, microalgal; protein tyrosine phosphatase inhibitors; purinenucleoside phosphorylase inhibitors; purpurins; pyrazoloacridine;pyridoxylated hemoglobin polyoxyethylene conjugate; raf antagonists;raltitrexed; ramosetron; ras farnesyl protein transferase inhibitors;ras inhibitors; ras-GAP inhibitor; retelliptine demethylated; rhenium Re186 etidronate; rhizoxin; ribozymes; RII retinamide; rogletimide;rohitukine; romurtide; roquinimex; rubiginone B1; ruboxyl; safingol;saintopin; SarCNU; sarcophytol A; sargramostim; Sdi 1 mimetics;semustine; senescence derived inhibitor 1; sense oligonucleotides;signal transduction inhibitors; signal transduction modulators; singlechain antigen binding protein; sizofiran; sobuzoxane; sodiumborocaptate; sodium phenylacetate; solverol; somatomedin bindingprotein; sonermin; sparfosic acid; spicamycin D; spiromustine;splenopentin; spongistatin 1; squalamine; stem cell inhibitor; stem-celldivision inhibitors; stipiamide; stromelysin inhibitors; sulfinosine;superactive vasoactive intestinal peptide antagonist; suradista;suramin; swainsonine; synthetic glycosaminoglycans; tallimustine;tamoxifen methiodide; tauromustine; tazarotene; tecogalan sodium;tegafur; tellurapyrylium; telomerase inhibitors; temoporfin;temozolomide; teniposide; tetrachlorodecaoxide; tetrazomine;thaliblastine; thalidomide; thiocoraline; thrombopoietin; thrombopoietinmimetic; thymalfasin; thymopoietin receptor agonist; thymotrinan;thyroid stimulating hormone; tin ethyl etiopurpurin; tirapazamine;titanocene dichloride; topotecan; topsentin; toremifene; totipotent stemcell factor; translation inhibitors; tretinoin; triacetyluridine;triciribine; trimetrexate; triptorelin; tropisetron; turosteride;tyrosine kinase inhibitors; tyrphostins; UBC inhibitors; ubenimex;urogenital sinus-derived growth inhibitory factor; urokinase receptorantagonists; vapreotide; variolin B; vector system, erythrocyte genetherapy; velaresol; veramine; verdins; verteporfin; vinorelbine;vinxaltine; vitaxin; vorozole; zanoterone; zeniplatin; zilascorb;zinostatin stimalamer.

[0161] Anti-cancer Supplementary Potentiating Agents: Tricyclicanti-depressant drugs (e.g., imipramine, desipramine, amitryptyline,clomipramine, trimipramine, doxepin, nortriptyline, protriptyline,amoxapine and maprotiline); non-tricyclic anti-depressant drugs (e.g.,sertraline, trazodone and citalopram); Ca⁺⁺ antagonists (e.g.,verapamil, nifedipine, nitrendipine and caroverine); Calmodulininhibitors (e.g., prenylamine, trifluoroperazine and clomipramine);Amphotericin B; Triparanol analogues (e.g., tamoxifen); antiarrhythmicdrugs (e.g., quinidine); antihypertensive drugs (e.g., reserpine); Thioldepleters (e.g., buthionine and sulfoximine) and Multiple DrugResistance reducing agents such as Cremaphor EL. The compounds of theinvention also can be administered with cytokines such as granulocytecolony stimulating factor.

[0162] Antineutropenic: Filgrastim; Lenograstim; Molgramostim;Regramostim; Sargramostim.

[0163] Antiobsessional agent: Fluvoxamine Maleate.

[0164] Antiparasitic: Abamectin; Clorsulon; Ivermectin.

[0165] Antiparkinsonian: Benztropine Mesylate; Biperiden; BiperidenHydrochloride; Biperiden Lactate; Carmantadine; Ciladopa Hydrochloride;Dopamantine; Ethopropazine Hydrochloride; Lazabemide; Levodopa;Lometraline Hydrochloride; Mofegiline Hydrochloride; NaxagolideHydrochloride; Pareptide Sulfate; Procyclidine Hydrochloride;Quinelorane Hydrochloride; Ropinirole Hydrochloride; SelegilineHydrochloride; Tolcapone; Trihexyphenidyl Hydrochloride.

[0166] Antiperistaltic: Difenoximide Hydrochloride; Difenoxin;Diphenoxylate Hydrochloride; Fluperamide; Lidamidine Hydrochloride;Loperamide Hydrochloride; Malethamer; Nufenoxole; Paregoric.

[0167] Antipneumocystic: Atovaquone.

[0168] Antiproliferative agent: Piritrexim Isethionate.

[0169] Antiprostatic hypertrophy: Sitogluside.

[0170] Antiprotozoal: Amodiaquine; Azanidazole; Bamnidazole;Carnidazole; Chlortetracycline Bisulfate; ChlortetracyclineHydrochloride; Flubendazole; Flunidazole; Halofuginone Hydrobromide;Imidocarb Hydrochloride; Ipronidazole; Metronidazole; Misonidazole;Moxnidazole; Nitarsone; Partricin; Puromycin; Puromycin Hydrochloride;Ronidazole; Sulnidazole; Tinidazole.

[0171] Antipruritic: Cyproheptadine Hydrochloride: Methdilazine;Methdilazine Hydrochloride; Trimeprazine Tartrate.

[0172] Antipsoriatic: Acitretin; Anthralin; Azaribine; Calcipotriene;Cycloheximide; Enazadrem Phosphate; Etretinate; Liarozole Fumarate;Lonapalene; Tepoxalin.

[0173] Antipsychotic: Acetophenazine Maleate; Alentemol Hydrobromide;Alpertine; Azaperone; Batelapine Maleate; Benperidol; BenzindopyrineHydrochloride; Brofoxine; Bromperidol; Bromperidol Decanoate; ButaclamolHydrochloride; Butaperazine; Butaperazine Maleate; Carphenazine Maleate;Carvotroline Hydrochloride; Chlorpromazine; ChlorpromazineHydrochloride; Chlorprothixene; Cinperene: Cintriamide; ClomacranPhosphate; Clopenthixol; Clopimozide; Clopipazan Mesylate; CloroperoneHydrochloride; Clothiapine; Clothixamide Maleate; Clozapine;Cyclophenazine Hydrochloride; Droperidol; Etazolate Hydrochloride;Fenimide; Flucindole; Flumezapine; Fluphenazine Decanoate; FluphenazineEnanthate; Fluphenazine Hydrochloride; Fluspiperone; Fluspirilene;Flutroline; Gevotroline Hydrochloride; Halopemide; Haloperidol;Haloperidol Decanoate; Iloperidone; Imidoline Hydrochloride; Lenperone;Mazapertine Succinate; Mesoridazine; Mesoridazine Besylate; Metiapine;Milenperone; Milipertine; Molindone Hydrochloride; NaranolHydrochloride; Neflumozide Hydrochloride; Ocaperidone; Olanzapine;Oxiperomide; Penfluridol; Pentiapine Maleate; Perphenazine; Pimozide;Pinoxepin Hydrochloride; Pipamperone; Piperacetazine; PipotiazinePalmitate; Piquindone Hydrochloride; Prochlorperazine Edisylate;Prochlorperazine Maleate; Promazine Hydrochloride; Remoxipride;Remoxipride Hydrochloride; Rimcazole Hydrochloride; SeperidolHydrochloride; Sertindole; Setoperone; Spiperone; Thioridazine;Thioridazine Hydrochloride; Thiothixene; Thiothixene Hydrochloride;Tioperidone Hydrochloride; Tiospirone Hydrochloride; TrifluoperazineHydrochloride; Trifluperidol; Triflupromazine; TriflupromazineHydrochloride; Ziprasidone Hydrochloride.

[0174] Antirheumatic: Auranofin; Aurothioglucose; Bindarit; LobenzaritSodium; Phenylbutazone; Pirazolac; Prinomide Tromethamine; Seprilose.

[0175] Antischistosomal: Becanthone Hydrochloride; Hycanthone;Lucanthone Hydrochloride; Niridazole; Oxamniquine; PararosanilinePamoate; Teroxalene Hydrochloride.

[0176] Antiseborrheic: Chloroxine; Piroctone; Piroctone Olamine;Resorcinol Monoacetate.

[0177] Antisecretory: Arbaprostil; Deprostil; Fenoctimine Sulfate;Octreotide; Octreotide Acetate; Omeprazole Sodium; Rioprostil;Trimoprostil.

[0178] Antispasmodic: Stilonium Iodide; Tizanidine Hydrochloride.

[0179] Antithrombotic: Anagrelide Hydrochloride; Bivalirudin; DalteparinSodium; Danaparoid Sodium; Dazoxiben Hydrochloride; Efegatran Sulfate;Enoxaparin Sodium; Ifetroban; Ifetroban Sodium; Tinzaparin Sodium;Trifenagrel.

[0180] Antitussive: Benzonatate; Butamirate Citrate; ChlophedianolHydrochloride; Codeine Polistirex; Codoxime; Dextromethorphan;Dextromethorphan Hydrobromide; Dextromethorphan Polistirex; EthylDibunate; Guaiapate; Hydrocodone Bitartrate; Hydrocodone Polistirex;Levopropoxyphene Napsylate; Noscapine; Pemerid Nitrate; Pipazethate;Suxemerid Sulfate.

[0181] Anti-ulcerative: Aceglutamide Aluminum; Cadexomer Iodine;Cetraxate Hydrochloride; Enisoprost; Isotiquimide; Lansoprazole;Lavoltidine Succinate; Misoprostol; Nizatidine; Nolinium Bromide;Pantoprazole; Pifamine; Pirenzepine Hydrochloride; Rabeprazole Sodium;Remiprostol; Roxatidine Acetate Hydrochloride; Sucralfate; SucrosofatePotassium; Tolimidone.

[0182] Anti-urolithic: Cysteamine; Cysteamine Hydrochloride; Tricitrates.

[0183] Antiviral: Acemannan; Acyclovir; Acyclovir Sodium; Adefovir;Alovudine; Alvircept Sudotox; Amantadine Hydrochloride; Aranotin;Arildone; Atevirdine Mesylate; Avridine; Cidofovir; Cipamfylline;Cytarabine Hydrochloride; Delavirdine Mesylate; Desciclovir; Didanosine;Disoxaril; Edoxudine; Enviradene; Enviroxime; Famciclovir; FamotineHydrochloride; Fiacitabine; Fialuridine; Fosarilate; Foscamet Sodium;Fosfonet Sodium; Ganciclovir; Ganciclovir Sodium; Idoxuridine; Kethoxal;Lamivudine; Lobucavir; Memotine Hydrochloride; Methisazone; Nevirapine;Penciclovir; Pirodavir; Ribavirin; Rimantadine Hydrochloride; SaquinavirMesylate; Somantadine Hydrochloride; Sorivudine; Statolon; Stavudine;Tilorone Hydrochloride; Trifluridine; Valacyclovir Hydrochloride;Vidarabine; Vidarabine Phosphate; Vidarabine Sodium Phosphate; Viroxime;Zalcitabine; Zidovudine; Zinviroxime.

[0184] Appetite suppressant: Dexfenfluramine Hydrochloride;Phendimetrazine Tartrate; Phentermine Hydrochloride.

[0185] Benign prostatic hyperplasia therapy agent: TamsulosinHydrochloride.

[0186] Blood glucose regulators: Human insulin; Glucagon; Tolazamide;Tolbutamide; Chloropropamide; Acetohexamide and Glipizide.

[0187] Bone resorption inhibitor: Alendronate Sodium; EtidronateDisodium; Pamidronate Disodium.

[0188] Bronchodilator: Albuterol; Albuterol Sulfate; Azanator Maleate;Bamifylline Hydrochloride; Bitolterol Mesylate; Butaprost; CarbuterolHydrochloride; Clorprenaline Hydrochloride; Colterol Mesylate;Doxaprost; Doxofylline; Dyphylline; Enprofylline; Ephedrine; EphedrineHydrochloride; Fenoterol; Fenprinast Hydrochloride; Guaithylline;Hexoprenaline Sulfate; Hoquizil Hydrochloride; Ipratropium Bromide;Isoetharine; Isoetharine Hydrochloride; Isoetharine Mesylate;Isoproterenol Hydrochloride; Isoproterenol Sulfate; MetaproterenolPolistirex; Metaproterenol Sulfate; Nisbuterol Mesylate; Oxtriphylline;Picumeterol Fumarate; Piquizil Hydrochloride; Pirbuterol Acetate;Pirbuterol Hydrochloride; Procaterol Hydrochloride; PseudoephedrineSulfate; Quazodine; Quinterenol Sulfate; Racepinephrine; RacepinephrineHydrochloride; Reproterol Hydrochloride; Rimiterol Hydrobromide;Salmeterol; Salmeterol Xinafoate; Soterenol Hydrochloride; SulfonterolHydrochloride; Suloxifen Oxalate; Terbutaline Sulfate; Theophylline;Xanoxate Sodium; Zindotrine; Zinterol Hydrochloride.

[0189] Carbonic anhydrase inhibitor: Acetazolamide; AcetazolamideSodium; Dichlorphenamide; Dorzolamide Hydrochloride; Methazolamide;Sezolamide Hydrochloride.

[0190] Cardiac depressant: Acecainide Hydrochloride; AcetylcholineChloride; Actisomide; Adenosine; Amiodarone; Aprindine; AprindineHydrochloride; Artilide Fumarate; Azimilide Dihydrochloride; Bidisomide;Bucainide Maleate; Bucromarone; Butoprozine Hydrochloride; CapobenateSodium; Capobenic Acid; Cifenline; Cifenline Succinate; ClofiliumPhosphate; Disobutamide; Disopyramide; Disopyramide Phosphate;Dofetilide; Drobuline; Edifolone Acetate; Emilium Tosylate; EncainideHydrochloride; Flecainide Acetate; Ibutilide Fumarate; IndecainideHydrochloride; Ipazilide Fumarate; Lorajmine Hydrochloride; LorcainideHydrochloride; Meobentine Sulfate; Mexiletine Hydrochloride;Modecainide; Moricizine; Oxiramide; Pirmenol Hydrochloride;Pirolazamide; Pranolium Chloride; Procainamide Hydrochloride;Propafenone Hydrochloride; Pyrinoline; Quindonium Bromide; QuinidineGluconate; Quinidine Sulfate; Recainam Hydrochloride; Recainam Tosylate;Risotilide Hydrochloride; Ropitoin Hydrochloride; SematilideHydrochloride; Suricainide Maleate; Tocainide; Tocainide Hydrochloride;Transcainide.

[0191] Cardioprotectant: Dexrazoxane; Draflazine.

[0192] Cardiotonic: Actodigin; Amrinone; Bemoradan; Butopamine;Carbazeran; Carsatrin Succinate; Deslanoside; Digitalis; Digitoxin;Digoxin; Dobutamine; Dobutamine Hydrochloride; Dobutamine Lactobionate;Dobutamine Tartrate; Enoximone; Imazodan Hydrochloride; Indolidan;Isomazole Hydrochloride; Levdobutamine Lactobionate; Lixazinone Sulfate;Medorinone; Milrinone; Pelrinone Hydrochloride; Pimobendan; Piroximone;Prinoxodan; Proscillaridin; Quazinone; Tazolol Hydrochloride;Vesnarinone.

[0193] Cardiovascular agent: Dopexamine; Dopexamine Hydrochloride.

[0194] Choleretic: Dehydrocholic Acid; Fencibutirol; Hymecromone;Piprozolin; Sincalide; Tocamphyl.

[0195] Cholinergic: Aceclidine; Bethanechol Chloride; Caibachol;Demecarium Bromide; Dexpanthenol; Echothiophate Iodide; Isoflurophate;Methacholine Chloride; Neostigmine Bromide; Neostigmine Methylsulfate;Physostigmine; Physostigmine Salicylate; Physostigmine Sulfate;Pilocarpine; Pilocarpine Hydrochloride; Pilocarpine Nitrate;Pyridostigmine Bromide.

[0196] Cholinergic agonist: Xanomeline; Xanomeline Tartrate.

[0197] Cholinesterase Deactivator: Obidoxime Chloride; PralidoximeChloride; Pralidoxime Iodide; Pralidoxime Mesylate.

[0198] Coccidiostat: Arprinocid; Narasin; Semduramicin; SemduramicinSodium.

[0199] Cognition adjuvant: Ergoloid Mesylates; Piracetam; PramiracetamHydrochloride; Pramiracetam Sulfate; Tacrine Hydrochloride.

[0200] Cognition enhancer: Besipirdine Hydrochloride; Linopirdine;Sibopirdine .

[0201] Depressant: Omeprazole.

[0202] Diagnostic aid: Aminohippurate Sodium; Anazolene Sodium;Arclofenin; Arginine; Bentiromide; Benzylpenicilloyl Polylysine;Butedronate Tetrasodium; Butilfenin; Coccidioidin; Corticorelin OvineTriflutate Corticotropin, Repository; Corticotropin Zinc Hydroxide;Diatrizoate Meglumine; Diatrizoate Sodium; Diatrizoic Acid; DiphtheriaToxin for Schick Test; Disofenin; Edrophonium Chloride; Ethiodized Oil;Etifenin; Exametazime; Ferristenc; Ferumoxides; Ferumoxsil; Fluorescein;Fluorescein Sodium; Gadobenate Dimeglumine; Gadoteridol; Gadodiamide;Gadopentetate Dimegiumine; Gadoversetamide; Histoplasmin; ImpromidineHydrochloride; Indigotindisulfonate Sodium; Indocyanine Green;lobenguane Sulfate I 123; lobenzamic Acid; Iocarmate Meglumine; locarmicAcid; locetamic Acid; lodamide; lodamide Megiumine; lodipamideMeglumine; lodixanol; lodoxamate Meglumine; lodoxamic Acid; loglicicAcid; loglucol; loglucomide; loglycamic Acid; logulamide; lohexol;lomeprol; lopamidol; lopanoic Acid; Iopentol; lophendylate; Iprofenin;Iopronic Acid; loprocemic Acid; lopydol; Iopydone; losefamic Acid;Ioseric Acid; losulamide Meglumine; losumetic Acid; Iotasul; IotetricAcid; Iothalamate Meglumine; lothalamate Sodium; lothalamic Acid;Iotrolan; lotroxic Acid; loversol; loxaglate Meglumine; IoxagiateSodium; Ioxaglic Acid; Ioxilan; Ioxotrizoic Acid; Ipodate Calcium;Ipodate Sodium; Isosulfan Blue; Leukocyte Typing Serum; Lidofenin;Mebrofenin; Meglumine; Metrizamide; Metrizoate Sodium; Metyrapone;Metyrapone Tartrate; Mumps Skin Test Antigen; Pentetic Acid;Propyliodone; Quinaldine Blue; Schick Test Control; Sermorelin Acetate;Sodium Iodide I 123; Sprodiamide; Stannous Pyrophosphate; StannousSulfur Colloid; Succimer; Teriparatide Acetate; Tetrofosmin; TolbutamideSodium; Tuberculin; Tyropanoate Sodium; Xylose.

[0203] Diuretic: Ambuphylline; Ambuside; Amiloride Hydrochloride;Azolimine; Azosemide; Brocrinat; Bumetanide; Chlorothiazide;Chlorthalidone; Clazolimine; Clorexolone; Ethacrynate Sodium; EthacrynicAcid; Etozolin; Fenquizone; Furosemide; Hydrochlorothiazide; Isosorbide;Mannitol; Mefruside; Ozolinone; Piretanide; Spiroxasone; Torsemide;Triamterene; Triflocin; Urea.

[0204] Dopaminergic agent: Ibopamine.

[0205] Ectoparasiticide: Nifluridide; Permethrin.

[0206] Emetic: Apomorphine Hydrochloride.

[0207] Enzyme inhibitor: Acetohydroxamic Acid; Alrestatin Sodium;Aprotinin; Benazepril Hydrochloride; Benazeprilat; Benurestat;Bromocriptine; Bromocriptine Mesylate; Cilastatin Sodium; Flurofamide;Lergotrile; Lergotrile Mesylate; Levcycloserine; Libenzapril; Pentopril;Pepstatin; Perindopril; Polignate Sodium; Sodium Amylosulfate; Sorbinil;Spirapril Hydrochloride; Spiraprilat; Taleranol; Teprotide; Tolfamide;Zofenopril Calcium.

[0208] Estrogen: Chlorotrianisene; Dienestrol; Diethylstilbestrol;Diethylstilbestrol Diphosphate; Equilin; Estradiol; Estradiol Cypionate;Estradiol Enanthate; Estradiol Undecylate; Estradiol Valerate;Estrazinol Hydrobromide; Estriol; Estrofurate; Estrogens, Conjugated;Estrogens, Esterified; Estrone; Estropipate; Ethinyl Estradiol;Fenestrel; Mestranol; Nylestriol; Quinestrol.

[0209] Fibrinolytic: Anistreplase; Bisobrin Lactate; Brinolase.

[0210] Free oxygen radical scavenger: Pegorgotein.

[0211] Gastrointestinal Motility agents: Cisapride (Propulsid);Metoclopramide (Reglan); Hyoscyamine (Levsin).

[0212] Glucocorticoid: Amcinonide; Beclomethasone Dipropionate;Betamethasone; Betamethasone Acetate; Betamethasone Benzoate;Betamethasone Dipropionate; Betamethasone Sodium Phosphate;Betamethasone Valerate; Carbenoxolone Sodium; Clocortolone Acetate;Clocortolone Pivalate; Cloprednol; Corticotropin; Corticotropin,Repository; Corticotropin Zinc Hydroxide; Cortisone Acetate; Cortivazol;Descinolone Acetonide; Dexamethasone; Dexamethasone Sodium Phosphate;Diflucortolone; Diflucortolone Pivalate; Flucloronide; Flumethasone;Flumethasone Pivalate; Flunisolide; Fluocinolone Acetonide;Fluocinonide; Fluocortolone; Fluocortolone Caproate; Fluorometholone;Fluperolone Acetate; Fluprednisolone; Fluprednisolone Valerate;Flurandrenolide; Formocortal; Hydrocortisone; Hydrocortisone Acetate;Hydrocortisone Buteprate; Hydrocortisone Butyrate; Hydrocortisone SodiumPhosphate; Hydrocortisone Sodium Succinate; Hydrocortisone Valerate;Medrysone; Methylprednisolone; Methylprednisolone Acetate;Methylprednisolone Sodium Phosphate; Methylprednisolone SodiumSuccinate; Nivazol; Paramethasone Acetate; Prednicarbate; Prednisolone;Prednisolone Acetate; Prednisolone Hemisuccinate; Prednisolone SodiumPhosphate; Prednisolone Sodium Succinate; Prednisolone Tebutate;Prednisone; Prednival; Ticabesone Propionate; Tralonide; Triamcinolone;Triamcinolone Acetonide; Triamcinolone Acetonide Sodium; TriamcinoloneDiacetate; Triamcinolone Hexacetonide.

[0213] Gonad-stimulating principle: Buserelin Acetate; ClomipheneCitrate; Ganirelix Acetate; Gonadorelin Acetate; GonadorelinHydrochloride; Gonadotropin, Chorionic; Menotropins.

[0214] Hair growth stimulant: Minoxidil.

[0215] Hemostatic: Aminocaproic Acid; Oxamarin Hydrochloride; Sulmarin;Thrombin; Tranexamic Acid.

[0216] Histamine H2 receptor antagonists: Ranitidine (Zantac);Famotidine (Pepcid); Cimetidine (Tagamet); Nizatidine (Axid).

[0217] Hormone: Diethylstilbestrol; Progesterone; 17 hydroxyprogesterone; Medroxyprogesterone; Norgestrel; Norethynodrel; Estradiol;Megestrol (Megace); Norethindrone; Levonorgestrel; Ethyndiol; Ethinylestradiol; Mestranol; Estrone; Equilin; 17 alpha dihydroequilin;equilenin; 17 alpha dihydroequilenin; 17 alpha estradiol; 17 betaestradiol; Leuprolide (lupron); Glucagon; Testolactone; Clomiphene; Hanmemopausal gonadotropins; Human chorionic gonadotropin; Urofollitropin;Bromocriptine; Gonadorelin; Luteinizing hormone releasing hormone andanalogs; Gonadotropins; Danazol; Testosterone; Dehydroepiandrosterone;Androstenedione; Dihydroestosterone; Relaxin; Oxytocin; Vasopressin;Folliculostatin; Follicle regulatory protein; Gonadoctrinins; Oocytematuration inhibitor; Insulin growth factor; Follicle StimulatingHormone; Luteinizing hormone; Tamoxifen.; Corticorelin Ovine Triflutate;Cosyntropin; Metogest; Pituitary, Posterior; Seractide Acetate;Somalapor; Somatrem; Somatropin; Somenopor; Somidobove.

[0218] Hypocholesterolemic: Lifibrol.

[0219] Hypoglycemic: Darglitazone Sodium: Glimepiride.

[0220] Hypolipidemic: Azalanstat Dihydrochloride; Colestolone; Surfomer;Xenalipin.

[0221] Hypotensive: Viprostol.

[0222] HMGCoA reductase inhibitors: Lovastatin (Mevacor); Simvastatin(Zocor); Pravastatin (Pravachol); Fluvasatin (Lescol).

[0223] Immunizing agent: Antirabies Serumn; Antivenin (Latrodectusmactans); Antivenin (Micrurus Fulvius); Antivenin (Crotalidae)Polyvalent; BCG Vaccine; Botulism Antitoxin; Cholera Vaccine; DiphtheriaAntitoxin; Diphtheria Toxoid; Diphtheria Toxoid Adsorbed; Globulin,Immune; Hepatitis B Immune Globulin; Hepatitis B Virus VaccineInactivated; Influenza Virus Vaccine; Measles Virus Vaccine Live;Meningococcal Polysaccharide Vaccine Group A; MeningococcalPolysaccharide Vaccine Group C; Mumps Virus Vaccine Live; PertussisImmune Globulin; Pertussis Vaccine; Pertussis Vaccine Adsorbed; PlagueVaccine; Poliovirus Vaccine Inactivated; Poliovirus Vaccine Live Oral;Rabies Immune Globulin; Rabies Vaccine; Rho(D) Immune Globulin; RubellaVirus Vaccine Live; Smallpox Vaccine; Tetanus Antitoxin; Tetanus ImmuneGlobulin; Tetanus Toxoid; Tetanus Toxoid Adsorbed; Typhoid Vaccine;Yellow Fever vaccine; Vaccinia Immune Globulin; Varicella-Zoster ImmuneGlobulin.

[0224] Immunomodulator: Dimepranol Acedoben; Imiquimod; InterferonBeta-lb; Lisofylline; Mycophenolate Mofetil; Prczatide Copper Acetate.

[0225] Immunoregulator: Azarole; Fanetizole Mesylate; Frentizole;Oxamisole Hydrochloride; Ristianol Phosphate; Thymopentin; Tilomisole.

[0226] Immunostimulant: Loxoribine; Teceleukin.

[0227] Immunosuppressant: Azathioprine; Azathioprine Sodium;Cyclosporine; Daltroban; Gusperimus Trihydrochloride; Sirolimus;Tacrolimus.

[0228] Impotence therapy adjunct: Delequamine Hydrochloride.

[0229] Inhibitor: Acarbose; Atorvastatin Calcium; Benserazide;Brocresine; Carbidopa; Clavulanate Potassium; Dazmegrel; Docebenone;Epoprostenol; Epoprostenol Sodium; Epristeride; Finasteride;Flurbiprofen Sodium; Furegrelate Sodium; Lufironil; Miglitol; Orlistat;Pimagedine Hydrochloride; Pirmagrel: Ponalrestat; Ridogrel; SulbactamBenzathine; Sulbactam Pivoxil; Sulbactam Sodium; Suronacrine Maleate;Tazobactam; Tazobactam Sodium; Ticlopidine Hydrochloride; TirilazadMesylate; Tolrestat; Velnacrine Maleate; Zifrosilone; Zileuton.

[0230] Keratolytic: Alcloxa; Aldioxa; Benzoyl Peroxide;Dibenzothiophene; Etarotene; Isotretinoin; Motretinide; PicotrinDiolamine; Resorcinol; Resorcinol Monoacetate; Salicylic Acid;Sumarotene; Tazarotene; Tetroquinone; Tretinoin.

[0231] LHRH agonist: Deslorelin: Goserelin; Histrelin; Lutrelin Acetate;Nafarelin Acetate.

[0232] Liver disorder treatment: Malotilate.

[0233] Luteolysin: Fenprostalene.

[0234] Memory adjuvant: Dimoxamine Hydrochloride; Ribaminol.

[0235] Mental performance enhancer: Aniracetam.

[0236] Mood regulator: Fengabine.

[0237] Mucolytic: Acetylcysteine: Carbocysteine; Domiodol.

[0238] Mucosal Protective agents: Misoprostol (Cytotec).

[0239] Mydriatic: Berefrine.

[0240] Nasal decongestant: Nemazoline Hydrochloride; PseudoephedrinePolistirex.

[0241] Neuroleptic: Duoperone Fumarate; Risperidone.

[0242] Neuromuscular blocking agent: Atracurium Besylate; CisatracuriumBesylate; Doxacurium Chloride; Gallamine Triethiodide; MetocurineIodide; Mivacurium Chloride; Pancuronium Bromide; Pipecuronium Bromide;Rocuronium Bromide; Succinylcholine Chloride; Tubocurarine Chloride;Vecuronium Bromide.

[0243] Neuroprotective: Dizocilpine Maleate.

[0244] NMDA antagonist: Selfotel.

[0245] Non-hormonal sterol derivative: Pregnenolone Succinate.

[0246] Oxytocic: Carboprost; Carboprost Methyl; Carboprost Tromethamine;Dinoprost; Dinoprost Tromethamine; Dinoprostone; Ergonovine Maleate;Meteneprost; Methylergonovine Maleate; Oxytocin; Sparteine Sulfate.

[0247] Plasminogen activator: Alteplase; Urokinase.

[0248] Platelet activating factor antagonist: Lexipafant.

[0249] Platelet aggregation inhibitor: Acadesine; Beraprost; BeraprostSodium; Ciprostene Calcium; Itazigrel; Lifarizine; Oxagrelate.

[0250] Post-stroke and post-head trauma treatment: Citicoline Sodium.

[0251] Potentiator: Pentostatin; Talopram Hydrochloride.

[0252] Progestin: Algestone Acetophenide; Amadinone Acetate: AnagestoneAcetate; Chlormadinone Acetate; Cingestol; Clogestone Acetate;Clomegestone Acetate; Desogestrel; Dimethisterone; Dydrogesterone;Ethynerone; Ethynodiol Diacetate; Etonogestrel; Flurogestone Acetate;Gestaclone; Gestodene; Gestonorone Caproate; Gestrinone;Haloprogesterone; Hydroxyprogesterone Caproate; Levonorgestrel;Lynestrenol; Medrogestone; Medroxyprogesterone Acetate; MethynodiolDiacetate; Norethindrone; Norethindrone Acetate; Norethynodrel;Norgestimate; Norgestomet; Norgestrel; Oxogestone Phenpropionate;Progesterone; Quingestanol Acetate; Quingestrone; Tigestol.

[0253] Prostaglandin: Cloprostenol Sodium; Fluprostenol Sodium;Gemeprost; Prostalene; Sulprostone.

[0254] Prostate growth inhibitor: Pentomone.

[0255] Prothyrotropin: Protirelin.

[0256] Psychotropic: Minaprine.

[0257] Pulmonary surface: Beractant; Colfosceril Palmitate.

[0258] Radioactive agent: Fibrinogen 1 125; Fludeoxyglucose F 18;Fluorodopa F 18; Insulin I 125; Insulin I 131; Iobenguane I 123;Iodiparnide Sodium I 131; lodoantipyrine I 131; Iodocholesterol I 131;Iodohippurate Sodium I 123; Iodohippurate Sodium I 125; IodohippurateSodium I 131; Iodopyracet I 125; Iodop-racet I 131; IofetamineHydrochloride I 123; Iomethin I 125; Iomethin I 131; Iothalamate SodiumI 125; Iothalamate Sodium I 131; Iotyrosine I 131; Liothyronine I 125;Liothyronine I 131. Merisoprol Acetate Hg 197; Merisoprol Acetate Hg203; Merisoprol Hg 197; Selenomethionine Se 75; Technetium Tc 99mAntimony Trisulfide Colloid; Technetium Tc 99m Bicisate; Technetium Tc99m Disofenin; Technetium Tc 99m Etidronate; Technetium Tc 99mExametazime; Technetium Tc 99m Furifosmin; Technetium Tc 99m Gluceptate;Technetium Tc 99m Lidofenin; Technetium Tc 99m Mebrofenin; Technetium Tc99m Medronate; Technetium Tc 99m Medronate Disodium; Technetium Tc 99mMertiatide; Technetium Tc 99m Oxidronate; Technetium Tc 99m Pentetate;Technetium Tc 99m Pentetate Calcium Trisodium; Technetium Tc 99mSestamibi; Technetium Tc 99m Siboroxime; Technetium Tc 99m Succimer;Technetium Tc 99m Sulfur Colloid; Technetium Tc 99m Teboroxime;Technetium Tc 99m Tetrofosmin; Technetium Tc 99m Tiatide; Thyroxine I125; Thyroxine I 131; Tolpovidone I 131; Triolein I 125; Triolein 1 131.

[0259] Regulator: Calcifediol; Calcitonin; Calcitriol; Clodronic Acid;Dihydrotachysterol; Etidronic Acid; Oxidronic Acid; Piridronate Sodium;Risedronate Sodium; Secalciferol.

[0260] Relaxant: Adiphenine Hydrochloride; Alcuronium Chloride;Aminophylline; Azumolene Sodium; Baclofen; Benzoctamine Hydrochloride;Carisoprodol; Chlorphenesin Carbamate; Chlorzoxazone; Cinflumide;Cinnamedrine; Clodanolene; Cyclobenzaprine Hydrochloride; Dantrolene;Dantrolene Sodium; Fenalamide; Fenyripol Hydrochloride; FetoxylateHydrochloride; Flavoxate Hydrochloride; Fletazepam; Flumetramide;Flurazepam Hydrochloride; Hexafluorenium Bromide; IsomylamineHydrochloride; Lorbamate; Mebeverine Hydrochloride; MesuprineHydrochloride; Metaxalone; Methocarbamol; Methixene Hydrochloride;Nafomine Malate; Nelezaprine Maleate; Papaverine Hydrochloride;Pipoxolan Hydrochloride; Quinctolate; Ritodrine; RitodrineHydrochloride; Rolodine; Theophylline Sodium Glycinate; ThiphenamilHydrochloride; Xilobam.

[0261] Repartitioning agent: Cimaterol.

[0262] Scabicide: Amitraz; Crotamiton.

[0263] Sclerosing agent: Ethanolamine Oleate; Morrhuate Sodium;Tribenoside.

[0264] Sedative: Propiomazine.

[0265] Sedative-hypnotic: Allobarbital; Alonimid; Alprazolam;Amobarbital Sodium; Bentazepam; Brotizolam; Butabarbital; ButabarbitalSodium; Butalbital; Capuride; Carbocloral; Chloral Betaine; ChloralHydrate; Chlordiazepoxide Hydrochloride; Cloperidone Hydrochloride;Clorethate; Cyprazepam; Dexclamol Hydrochloride; Diazepam;Dichloralphenazone; Estazolam; Ethchlorvynol; Etomidate; Fenobam;Flunitrazepam; Fosazepam; Glutethimide; Halazepam; Lormetazepam;Mecloqualone; Meprobamate; Methaqualone; Midaflur; Paraldehyde;Pentobarbital; Pentobarbital Sodium; Perlapine; Prazepam; Quazepam;Reclazepam; Roletamide; Secobarbital; Secobarbital Sodium; Suproclone;Thalidomide; Tracazolate; Trepipam Maleate; Triazolam; Tricetamide;Triclofos Sodium; Trimetozine; Uldazepam; Zaleplon; ZolazepamHydrochloride; Zolpidem Tartrate.

[0266] Selective adenosine A1 antagonist: Apaxifylline.

[0267] Serotonin antagonist: Altanserin Tartrate; Amesergide;Ketanserin; Ritanserin.

[0268] Serotonin inhibitor: Cinanserin Hydrochloride; Fenclonine;Fonazine Mesylate; Xylamidine Tosylate.

[0269] Serotonin receptor antagonist: Tropanserin Hydrochloride.

[0270] Steroid: Dexamethasone Acefurate; Mometasone Furoate.

[0271] Stimulant: Amfonelic Acid; Amphetamine Sulfate; Ampyzine Sulfate;Arbutamine Hydrochloride; Azabon; Caffeine; Ceruletide; CeruletideDiethylamine; Cisapride; Dazopride Fumarate; Dextroamphetamine;Dextroamphetamine Sulfate; Difluanine Hydrochloride; DimeflineHydrochloride; Doxapram Hydrochloride; Etryptamine Acetate; Etharnivan;Fenethylline Hydrochloride; Flubanilate Hydrochloride; Flurothyl;Histamine Phosphate; Indriline Hydrochloride; Mefexamide;Methamphetamine Hydrochloride; Methylphenidate Hydrochloride; Pemoline;Pyrovalerone Hydrochloride; Xamoterol; Xamoterol Fumarate.

[0272] Suppressant: Amflutizole; Colchicine: Tazofelone.

[0273] Symptomatic multiple sclerosis: Fampridine.

[0274] Synergist: Proadifen Hydrochloride.

[0275] Thyroid hormone: Levothyroxine Sodium; Liothyronine Sodium;Liotrix.

[0276] Thyroid inhibitor: Methimazole; Propylthiouracil.

[0277] Thyromimetic: Thyromedan Hydrochloride.

[0278] Tranquilizer: Bromazepam; Buspirone Hydrochloride;Chlordiazepoxide; Clazolam; Clobazam; Clorazepate Dipotassium;Clorazepate Monopotassium; Demoxepam; Dexmedetomidine; EnciprazineHydrochloride; Gepirone Hydrochloride; Hydroxyphenamate; HydroxyzineHydrochloride; Hydroxyzine Pamoate; Ketazolam; Lorazepam; Lorzafone;Loxapine; Loxapine Succinate; Medazepam Hydrochloride; Nabilone;Nisobamate; Oxazepam; Pentabamate; Pirenperone; Ripazepam; Rolipram;Sulazepam; Taciamine Hydrochloride; Temazepam; Triflubazam; Tybamate;Valnoctamide.

[0279] Amyotrophic lateral sclerosis agents: Riluzole.

[0280] Cerebral ischemia agents: Dextrorphan Hydrochloride.

[0281] Paget's disease agents: Tiludronate Disodium.

[0282] Unstable angina agents: Tirofiban Hydrochloride.

[0283] Uricosuric: Benzbromarone; Irtemazole; Probenecid;Sulfinpyrazone.

[0284] Vasoconstrictor: Angiotensin Amide; Felypressin; Methysergide;Methysergide Maleate.

[0285] Vasodilator: Alprostadil; Azaclorzine Hydrochloride; BamethanSulfate; Bepridil Hydrochloride; Buterizine; Cetiedil Citrate; ChromonarHydrochloride; Clonitrate; Diltiazem Hydrochloride; Dipyridamole;Droprenilamine; Erythrityl Tetranitrate; Felodipine; FlunarizineHydrochloride; Fostedil; Hexobendine; Inositol Niacinate; IproxamineHydrochloride; Isosorbide Dinitrate; Isosorbide Mononitrate; IsoxsuprineHydrochloride; Lidoflazine; Mefenidil; Mefenidil Fumarate; MibefradilDihydrochloride; Mioflazine Hydrochloride; Mixidine; Nafronyl Oxalate;Nicardipine Hydrochloride; Nicergoline; Nicorandil; Nicotinyl Alcohol;Nifedipine; Nimodipine; Nisoldipine; Oxfenicine; OxprenololHydrochloride; Pentaerythritol Tetranitrate; Pentoxifylline;Pentrinitrol; Perhexiline Maleate; Pindolol; Pirsidomine; Prenylamine;Propatyl Nitrate; Suloctidil; Terodiline Hydrochloride; TipropidilHydrochloride; Tolazoline Hydrochloride; Xanthinol Niacinate.

[0286] Vulnerary: Allantoin.

[0287] Wound healing agent: Ersofermin.

[0288] Xanthine oxidase inhibitor: Allopurinol; Oxypurinol

[0289] Other pharrnaceutical agents include: 1-decpyrrolidinone;1-dodecpyrrolidinone; 16-alpha fluoroestradiol; 16-epiestriol;16alpha-gitoxin; 17alpha estradiol; 17beta estradiol;1alpha-hydroxyvitamin D2; 2′-nor-cGMP; 20-epi-1,25 dihydroxyvitamin D3;22-oxacalcitriol; 2CVV; 3-isobutyl GABA; 6-FUDCA; 7-methoxytacrine;abamectin; abanoquil; abecamil; abiraterone; acadesine; acamprosate;acarbose; aceclofenac; acemannan; acetomepregenol; acetyl-L-camitine;acetylcysteine, N-; acetylmethadol; acifran; acipimox; acitemate;acitretin; aclarubicin; aclatonium; napadisilate; aconiazide;acrivastinet; adafenoxate; adapalene; adatanserin; adecypenol; adefovirdipivoxil; adelmidrol; ademetionine; adinazolam; adiposin; adozelesin;adrafinil; alacepril; aladapcin; alaptide; albendazole; albolabrin;aldecalmycin; aldesleukin; alendronic acid; alentemol; alfacalcidol;alfuzosin; alglucerase; alinastine; alosetron; alpha idosone;alprostadil; altretamine; altromycin B; ambamustine; amelometasone;amesergide; amezinium metilsulfate; amfebutamone; amidox; amifloxacin;amifostine; amiodarone; amisulpride; amlexanox; amlodipine; amlodipine;ampiroxicam; amrinone; amrubicin; amsacrine; amylin; amythiamicin;anagrelide; anakinra; ananain; anaritide; anastrozole; andrographolide;anordrin; apadoline; apafant; apaxifylline; aphidicolin glycinate;apraclonidine; aprosulate sodium; aptiganel; apurinic acid; aranidipine;arbekacin; arbidol; arbutamine; ardeparin sodium; arecatannin B1;argatroban; aripiprazol; arotinolol; asimadoline; aspalatone;asperfuran; aspoxicillin; astemizole; asulacrine; atamestane; atenolol,S-; atevirdine; atosiban; atovaquone; atpenin B; atrimustine;atrinositol; aureobasidin A; azadirachtine; azasetron; azatyrosine;azelaic acid; azelastine; azelnidipine; azimilide; azithromycin;azosemide; aztreonam; baccatin III; bacoside A; bacoside B;bactobolamine; balazipone; balhimycin;. balofloxacin; balsalazide;bambuterol; baohuoside 1; barnidipine; basifungin; batebulast;batimastat; beauvericin; becaplermin; becliconazole; befloxatone;belfosdil; bellenamine; benflumetol; benidipine; benzisoxazole;benzochlorins; benzoidazoxan; benzoylstaurosporine; benztropine;bepridil; beractant; beraprost; berlafenone; bertosamil; besipirdine;beta-alethine; betaclamycin B; betamipron; betaxolol; betulinic acid;bevantolol; bicalutamide; bifemelane; bimakalim; bimithil; binospirone;bioxalomycin alpha2; biriperone; bis-benzimidazole A; bis-benzimidazoleB; bisantrene; bisaramil; bisaziridinylspermine; bisnafide; bisoprolol;bistramide D; bistramide K; bistratene A; boldine; bopindolol;brefeldin; breflate; brimonidine; bromfenac; bromperidol; bropirimine;bucindolol; budesonide; budipine; budotitane; bunaprolast; bunazosin;butenafine; buthionine sulfoximine; butixocort propionate; cadexomeriodine; calanolide A; calcipotriol; calphostin C; camonagrel;candesartan; candesartan cilexetil; candoxatril; candoxatrilat;capecitabine; capromab; capsaicin; captopril; carbazomycin C;carbetocin; carbovir; carboxamide-amino-triazole; carboxyamidotriazole;carboxymethylated beta-1,3-glucan; carperitide; carteolol; carumonam;carvedilol; carvotroline; carzelesin; castanospermine; cebaracetam;cecropin B; cefcapene pivoxil; cefdaloxime pentexil tosilate; cefdinir;cefditoren pivoxil; cefepime; cefetamet; cefetamet pivoxil; cefixime;cefluprenam; cefmetazole; cefminox; cefodizime; cefoselis; cefotetan;cefotiam; cefotiam hexetil; cefozopran; cefpimizole; cefpiramide;cefpirome; cefpodoxime proxetil; cefprozil; cefsulodin; cefteram;ceftibuten; ceftriaxone; cefuroxime axetil; celastrol; celikalim;celiprolol; cepacidine A; cericlamine; cerivastatin; ceronapril;certoparin sodium; cetiedil; cetirizine; chloroorienticin A;chloroorienticin B; chloroquinoxaline sulfonamide; cibenzoline;cicaprost; ciclesonide; cicletanine; cicloprolol; cidofovir;cilansetron; cilazapril; cilnidipine; cilobradine; cilostazol;cimetropium bromide; cinitapride; cinolazepam; cioteronel; ciprofibrate;ciprofloxacin; ciprostene; cis-porphyrin; cisapride; cisatracuriumbesilate; cistinexine; citalopram; citicoline; citreamicin alpha;cladribine; clarithromycin; clausenamide; clebopride; clinafloxacin;clobazam; clobetasone butyrate; clodronic acid; clomethiazole;clopidogrel; clotrimazole; colestimide; colfosceril palmitate;collismycin A; collismycin B; combretastatin A4; complestatin;conagenin; contignasterol; contortrostatin; cosalane; costatolide;cotinine; coumermycin Al; cucumariosid; curacin A; curdlan sulfate;curiosin; cyclazosin; cyclic HPMPC; cyclobenzaprine; cyclobut A;cyclobut G; cyclocapron; cycloplatam; cyclosin; cyclothialidine;cyclothiazomycin; cypemycin; cyproterone; cytarabine ocfosfate;cytochalasin B; dacliximab; dactimicin; daidzein; daidzin; dalfopristin;dalteparin sodium; danaparoid; daphnodorin A; dapiprazole; dapitant;darifenacin; darlucin A; darsidomine; ddUTP; decitabine; deferiprone;deflazacort; dehydrodidemnin B; dehydroepiandrosterone; delapril;delequamine; delfaprazine; delmopinol; delphinidin; deoxypyridinoline;deprodone; depsidomycin; deramciclane; dermatan sulfate; desflurane;desirudin; deslorelin; desmopressin; desogestrel; desoxoamiodarone;detajmium bitartrate; dexifosfamide; dexketoprofen; dexloxiglumide;dexmedetomidine; dexpemedolac; dexrazoxane; dexsotalol; dextrin2-sulphate; dexverapamil; dezinamide; dezocine; diaziquone; diclofenacdigolil; diclofenac potassium; dicranin; didemnin B; didox; dienogest;diethylhomospermine; diethylnorspermine; dihydrexidine;dihydro-5-azacytidine; dimethyl prostaglandin A1; dimethylhomospermine;dimiracetam; dioxamycin; diphencyprone; diphenyl spiromustine;diprafenone; dipropylnorspermine; dirithromycin; discodermolide;disulfiram; ditekiren; docarpamine; docosanol, 1-; dofetilide;dolasetron; domitroban; dopexamine; dorzolamide; dosmalfale; dotarizine;doxacurium chloride; doxazosin; doxifluridine; doxofylline; draculin;draflazine; droloxifene; dronabinol; drosperidone; drotaverineacephyllinate; droxicam; ebiratide; ebrotidine; ebselen; ecabapide;ecabet; ecadotril; ecdisteron; echicetin; echistatin; ecomustine;ecteinascidin 722; ecteinascidin 729; ecteinascidin 743; edaravone;edelfosine; edobacomab; edrecolomab; efegatran; eflomithine;efonidipine; egualen; elcatonin; eletriptan; elgodipine; eliprodil;eltenac; emakalim; emedastine; emiglitate; emitefur; emoctakin;enadoline hydrochloride; enalapril; enazadrem; englitazone; enlimomab;enoxacin; enoxaparin sodium; enoximone; entacapone; enterostatin;epoprostenol; epoxymexrenone; epristeride; eprosartan; eptastigmine;erdosteine; ersentilide; ersofermin; erythritol; esuprone; etanidazole;etanterol; ethacizin; ethinylestradiol; etizolam; etodolac; etoposidephosphate; etrabamine; everninomicin; examorelin; exemestane; fadrozole;faeriefungin; famciclovir; fampridine; fantofarone; faropenem;fasidotril; fasudil; fazarabine; fedotozine; felbamate; fenofibrate;fenoldopam; fenretinide; fenspiride; fenticonazole; fepradinol;ferpifosate sodium; ferristene; ferrixan; ferumoxsil; fexofenadine;flavopiridol; flecainide; flerobuterol; fleroxacin; flesinoxan;flezelastine; flobufen; flomoxef; florfenicol; florifenine; flosatidil;fluasterone; fluconazole; fludarabine; flumazenil; flumecinol;flumequine; flunarizine; fluocalcitriol; fluorodaunorunicinhydrochloride; fluoxetine, R-; fluoxetine, S-; fluparoxan; flupirtine;flurbiprofen axetil; flurithromycin; fluticasone propionate;flutrimazole; fluvastatin; fluvoxamine; forasartan; forfenimex;formestane; formoterol; formoterol, R,R-; fosfomycin; trometamol;fosinopril; fosphenytoin; fostriecin; fotemustine; gabapentin; gadobenicacid; gadobutrol; gadodiamide; gadodiamide-EOB-DTPA; gadoliniumtexaphyrin; gadoteric acid; gadoteridol; gadoversetamide; galantamine;galdansetron; gallopamil; galocitabine; gamolenic acid; ganirelix;gepirone; gestrinone; girisopam; glaspimod; glaucocalyxin A;glutapyrone; glycopine; glycopril; granisetron; grepafloxacin;halichondrin B; halofantrine; halomon; halopredone; hatomamicin;hatomarubigin A; hatomarubigin B; hatomarubigin C; hatomarubigin D;ibogaine; ibopamine; ibudilast; illimaquinone; ilmofosine; ilomastat;iloperidone; iloprost; imidapril; imidazenil; indinavir; indolidan;indometacin farnesil; indometacin; tropine ester; indoramin;inocoterone; inogatran; inolimomab; interferon alfa; interferon alfa-2a;interferon alfa-2b; interferon alfa-N 1; interferon alfa-n3; interferonbeta; interferon beta-1al; interferon beta-1b; interferon gamma-1a;interferon gamma-1b; interferon omega; interferon, consensus;interleukin- 1; interleukin-1 alpha; interleukin-1 beta; interleukin-10;interleukin-11; interleukin-12; interleukin-12; interleukin-15;interleukin-2; interleukin-3; interleukin-4; interleukin-5;interleukin-7; interleukin-8; iobenguane; iobitridol; iodoamiloride;iododoxorubicin; iofratol; iomeprol; iopentol; iopromide; iopyrol;iotriside; ioversol; ioxilan; ipazilide; IpdR; ipenoxazone; ipidacrine;ipomeanol, 4-; ipriflavone; ipsapirone; irbesartan; irinotecan;irloxacin; irsogladine; irtemazole; isalsteine; isbogrel; isepamicin;isobengazole; isofloxythepin; isohomohalicondrin B; isopropylunoprostone; isradipine; itameline; itasetron; itopride; itraconazole;ketoprofen, R-; ketoprofen, S-; ketorolac; lacidipine; lactitol;lactivicin; laennec; lafutidine; lamellarin-N triacetate; lamifiban;lamivudine; lamotrigine; lanoconazole; lanperisone; lanreotide;lansoprazole; latanoprost; lateritin; laurocapram; lazabemide;lemefloxacin; lemildipine; leminoprazole; lenercept; lenograstim;lentinan sulfate; leptin; leptolstatin; lercanidipine; lerisetron;lesopitron; letrazuril; letrozole; leucomyzin; leuprorelin;levcromakalim; levetiracetam; levobetaxolol; levobunolol;levobupivacaine; levocabastine; levocarnitine; levodropropizine;levofloxacin; levomoprolol; levonorgestrel; levormeloxifene;levosimendan; levosulpiride; linotroban; linsidomine; lintitript;lintopride; liothyronine sodium; lirexapride; lisinopril; lobaplatin;lobucavir; lodoxamide; lombricine; lomefloxacin; lomerizine; lometrexol;lonazolac; lonidamine; loracarbef; loratadine; lorglumide; lomoxicam;losartan; losigamone; losoxantrone; loteprednol; loviride; loxoribine;lubeluzole; lurtotecan; luteinizing hormone; lutetium; luzindole;lydicamycin; lysofylline; lysostaphin; magainin 2 amide; magnolol;mallotochromene; mallotojaponin; malotilate; mangafodipir; manidipine;maniwamycin A; mannostatin A; manumycin E; manumycin F; mapinastine;marimastat; Martek 8708; Martek 92211; masoprocol; maspin; massetolide;meterelin; methoxatone; methylhistamine, R-alpha; methylinosinemonophosphate; methylprednisolone aceponate; methylprednisolonesuleptanate; metipamide; metoclopramide; metoprolol, S-; metrifonate;mibefradil; michellamine B; microcolin A; midodrine; mifepristone;miglitol; milacemide; milameline; mildronate; milnacipran; milrinone;miltefosine; minaprine; miokamycin; mipragoside; mirfentanil;mirimostim; mirtazapine; misoprostol; mitoguazone; mitolactol;mitonafide; mitoxantrone; mivacurium chloride; mivazerol; mixanpril;mizolastine; mizoribine; moclobemide; modafinil; moexipril; mofarotene;mofezolac; molgramostim; mometasone; montirelin; mopidamol; moracizine;mosapramine; mosapride; motilide; moxiraprine; moxonidine; nadifloxacin;nadroparin calcium; nafadotride; nafamostat; nafarelin; naftopidil;naglivan; nagrestip; nalmefene; naphterpin; napsagatran; naratriptan;nartograstim; nasaruplase; nateplase; niperotidine; niravoline;nisamycin; nisin; nisoldipine; nitazoxanide; nitecapone; nitrendipine;nitrendipine, S-; nitrofurantoin monohydrate; nitrullyn; nizatidine;ofloxacin; okicenone; olanzapine; olopatadine; olprinone; olsalazine;omeprazole; onapristone; ondansetron; ondansetron, R-; ontazolast;oracin; otenzepad; oxaliplatin; oxamisole; oxandrolone; oxaprozin;oxaunomycin; oxcarbazepine; oxiconazole; oxiracetam; oxodipine; ozagrel;palauamine; palinavir; palmitoylrhizoxin; pamaqueside; pamicogrel;pamidronic acid; panamesine; panaxytriol; panipenem; panipenum;pannorin; panomifene; pantethine; pantoprazole; parabactin; pamaparinsodium; paroxetine; parthenolide; pazelliptine; pazufloxacin;pefloxacin; pegaspargase; peldesine; pemedolac; pemirolast; penciclovir;pentafuside; pentamidine; pentamorphone; pentigetide; pentosan;pentostatin; pentrozole; perflubron; perfosfamide; pergolide;perindoprilat; perospirone; phenaridine; phenazinomycin; phenserine;phensuccinal; phentolamine mesilate; phenylacetate; phenylalanylketoconazole; picenadol; picibanil; picroliv; picumeterol; pidotimod;pilocarpine hydrochloride; pilsicainide; pimagedine; pimilprost;pimobendan; pinacidil; pinocebrin; pioglitazone; pipecuronium bromide;pirarubicin; piretanide; pirfenidone; piritrexim; pirlindole; pirmagrel;pirmenol; pirodavir; pirodomast; piroxicam cinnamate; propagermanium;propentofylline; propionylcarnitine, L-; propiram; propiram +paracetamol; propiverine; propyl bis-acridone; prostaglandin J2;prostratin; protegrin; protosufloxacin; prulifloxacin; pyrazoloacridine;quazepam; quetiapine; quiflapon; quinagolide; quinapril; quinfamide;quinupristin; raloxifene; raltitrexed; ramatroban; ramipril; ramosetron;ranelic acid; ranitidine bismuth citrate; ranolazine; recainam;regavirumab; relaxin; repirinast; resinferatoxin; reticulon; reviparinsodium; revizinone; ricasetron; ridogrel; rifabutin; rifapentine;rifaximin; rilopirox; riluzole; rimantadine; rimexolone; rimoprogin;riodipine; ripisartan; risedronic acid; rispenzepine; risperidone;ritanserin; ritipenem; ritipenem acoxil; ritolukast; ritonavir;rizatriptan benzoate; rohitukine; rokitamycin; ropinirole; ropivacaine;roquinimex; roxatidine; roxindole; roxithromycin; rubiginone B1;ruboxyl; rufloxacin; rupatidine; ruzadolane; safingol; safironil;saintopin; salbutamol, R-; salmeterol; salmeterol, R-salnacedin;sameridine; sampatrilat; sanfetrinem; saprisartan; sapropterin;saquinavir; SarCNU; sarcophytol A sargramostim; sarpogrelate; saruplase;saterinone; satigrel; satumomab pendetide; selegiline; seleniumthiosemicarbazone; sematilide; semduramicin; semotiadil; semustine;sermorelin; sertaconazole; sertindole; sertraline; setiptiline;sevirumab; sevoflurane; sezolamide; silipide; silteplase; simendan;simvastatin; sinitrodil; sinnabidol; sipatrigine; sirolimus; sizofiran;somatomedin B; somatomedin C; somatrem; somatropin; sonermin; sotalol;staurosporine; stavudine; stepronin; stipiamide; stiripentol; stobadine;succibun; sucralfate; sulfasalazine; sulfinosine; sulfoxamine;sulopenem; sultamicillin; sultopride; sulukast; sumatriptan; symakalim;tandospirone; tapgen; taprostene; tasosartan; tazanolast; tazarotene;teicoplanin; telenzepine; tellurapyrylium; telmesteine; telmisartan;temocapril; temoporfin; temozolomide; tenidap; teniposide; tenosal;tenoxicam; tepirindole; tepoxalin; terazosin; terbinafme; terfenadine;terflavoxate; terguride; terlakiren; terlipressin; terodiline;tertatolol; testosterone buciclate; tetrachlorodecaoxide; tetrazomine;thaliblastine; thalidomide; thiocoraline; thiofedrine; thiomarinol;thioperamide; thyroid stimulating hormone; tiagabine; tianeptine;tiapafant; tibolone; ticlopidine; tienoxolol; tilisolol; tilnoprofenarbamel; tiludronic acid; tinzaparin sodium; tiotropium bromide;tipredane; tiqueside; tirandalydigin; tirapazamine; tirilazad;tirofiban; tiropramide; topsentin; torasemide; toremifene; tosufloxacin;trafermin; trandolapril; traxanox; tretinoin; tretinoin tocoferil;triacetyluridine; tricaprilin; trichohyalin; trichosanthin, alpha;triciribine; trientine: triflavin; trimegestone; triptorelin;troglitazone; trombodipine; tropisetron; trospectomycin; trovafloxacin;trovirdine; tucaresol; tulobuterol; tylogenin; urapidil; uridinetriphosphate; valaciclovir; valproate magnesium; valproate semisodium;valsartan; vamicamide; vanadeine; vaninolol; vapreotide; variolin B;velaresol; venlafaxine; veramine; verapamil, (S); verdins; veroxan;verteporfin; vesnarinone; vexibinol; vigabatrin; vinbumine citrate;vinbumine resinate: vinconate; vinorelbine; vinpocetine; vinpocetinecitrate; vintoperol; vinxaltine; voriconazole; vorozole; voxergolide;xemilofiban; ximoprofen; yangambin; zabicipril; zacopride; zacopride,R-; zafirlukast; zalcitabine; zaleplon; zalospirone; zaltoprofen;zanamivir; zankiren; zanoterone; zatebradine; zatosetron; zenarestat;zeniplatin; zifrosilone; zilascorb; zileuton; zinostatin stimalamer;ziprasidone; zoledronic acid; zolmitriptan; zolpidem; zonisamide;zopiclone; zopiclone, S-; zopolrestat; zotepine.

[0290] The invention also embraces novel compositions of matter that arecovalent conjugates of unbranched, naturally occurring fatty acids andpharmaceutical agents that are noncentral nervous system active agents.Noncentral nervous system active agents have no function or use withinthe central nervous system. Their only use is outside of the centralnervous system. Such agents include all drugs within certain of theforegoing categories and only some drugs within other of the foregoingcatagories. For example, the entire catagory of blood glucose regulatorshave no use or function within the central nervous system. In contrast,certain anti-cancer agents are useful in the central nervous systemwhereas others are not. For example, central nervous system cancers arenot hormone dependent, and, therefore, an anti-cancer agent such asTamoxifen which treats certain hormone dependent cancers is not usefulin the central nervous system. Those skilled in the art will be able toidentify readily those catagories and/or members of a catagory which arenoncentral nervous system active agents. Among the foregoing compounds,the following catagories and/or members of the following catagories arenoncentral nervous system active agents: adrenocortical steroid;adrenocortical suppressant; aldosterone antagonist; amino acid;anabolic; androgen; antagonist; anthelmintic; anti-acne agent;anti-adrenergic; anti-allergic; anti-amebic; anti-androgen; anti-anemic;anti-anginal; anti-arthritic; anti-asthmatic; anti-atherosclerotic;antibacterial; anticholelithic; anticholelithogenic; anticholinergic;anticoagulant; anticoccidal; antidiabetic; antidiarrheal; antidiuretic;antidote; anti-estrogen; antifibrinolytic; antifungal;antiglaucomaagent; antihemophilic; antihemorrhagic; antihistamine;antihyperlipidemia; antihyperlipoproteinemic; antihypertensive;antihypotensive; anti-infective; anti-infective, topical;anti-inflammatory; antikeratinizing agent; antimalarial; antimicrobial;antimitotic; antimycotic, antineoplastic. antineutropenic,antiparasitic; antiperistaltic, antipneumocystic; antiproliferative;antiprostatic hypertrophy; antiprotozoal; antipruritic; antipsoriatic;antirheumatic; antischistosomal; antiseborrheic; antisecretory;antispasmodic; antithrombotic; antitussive; anti-ulcerative;anti-urolithic; antiviral; appetite suppressant; benign prostatichyperplasia therapy agent; bone resorption inhibitor; bronchodilator;carbonic anhydrase inhibitor; cardiac depressant; cardioprotectant;cardiotonic; cardiovascular agent; choleretic; cholinergic; cholinergicagonist; cholinesterase deactivator; coccidiostat; diagnostic aid;diuretic; ectoparasiticide; enzyme inhibitor; estrogen; fibrinolytic;free oxygen radical scavenger; glucocorticoid; gonad-stimulatingprinciple; hair growth stimulant; hemostatic; hormone;hypocholesterolemic; hypoglycernic; hypolipidemic; hypotensive;immunizing agent; immunomodulator; immunoregulator; immunostimulant;immunosuppressant; impotence therapy adjunct; inhibitor; keratolytic;LHRH agonist; liver disorder treatment; luteolysin; mucolytic;mydriatic; nasal decongestant; neuromuscular blocking agent;non-hormonal sterol derivative; oxytocic; plasminogen activator;platelet activating factor antagonist; platelet aggregation inhibitor;potentiator; progestin; prostaglandin; prostate growth inhibitor;prothyrotropin; pulmonary surface; radioactive agent; regulator;relaxant; repartitioning agent; scabicide; sclerosing agent; selectiveadenosine Al antagonist; steroid; suppressant; symptomatic multiplesclerosis; synergist; thyroid hormone; thyroid inhibitor; thyromimetic;amyotrophic lateral sclerosis agents; Paget's disease agents; unstableangina agents; uricosuric; vasoconstrictor; vasodilator; vulnerary;wound healing agent; xanthine oxidase inhibitor.

[0291] As used herein, a taxane is a molecule that possesses thefollowing tricyclic carbon-atom connectivity network, which mayincorporate carbon-carbon multiple bonds, and which through theinvolvement of carbon-atom-noncarbon-atom bonds may includesubstituents, functional groups, and additional rings.

[0292] A taxoid is a molecule structurally related to a taxane in whichthe above taxane carbon-atom connectivity network is altered, forexample, by cleavage of one or more of the carbocyclic rings, bydeletion or addition of carbon substituents, by connection of carbonatoms normally not bonded to each other, by disconnection of carbonatoms normally bonded to each other, or by some other reorganization ofor adjustment to the taxane carbon-atom connectivity network, but inwhich one or more structural features characteristic of the taxanecarbon-atom connectivity network are conserved.

[0293] The compounds useful in the invention may be delivered in theform of anti-cancer cocktails. An anti-cancer cocktail is a mixture ofany one of the compounds useful with this invention with anotheranti-cancer agent such as an anti-cancer drug, a cytokine, and/orsupplementary potentiating agent(s). The use of cocktails in thetreatment of cancer is routine. In this embodiment, a commonadministration vehicle (e.g., pill, tablet, implant, injectablesolution, etc.) would contain both the conjugate useful in thisinvention and the anti-cancer drug and/or supplementary potentiatingagent.

[0294] The compounds of the invention, when used in cocktails, areadministered in therapeutically effective amounts. A therapeuticallyeffective amount will be determined by the parameters discussed below;but, in any event, is that amount which establishes a level of thedrug(s) in the area of the tumor which is effective in inhibiting thetumor growth.

[0295] When administered, the formulations of the invention are appliedin pharmaceutically acceptable amounts and in pharmaceuticallyacceptable compositions. Such preparations may routinely contain salts,buffering agents, preservatives, compatible carriers, and optionallyother therapeutic ingredients. When used in medicine the salts should bepharmaceutically acceptable, but non-pharmaceutically acceptable saltsmay conveniently be used to prepare pharmaceutically acceptable saltsthereof and are not excluded from the scope of the invention. Suchpharmacologically and pharmaceutically acceptable salts include, but arenot limited to, those prepared from the following acids: hydrochloric,hydrobromic, sulphuric, nitric, phosphoric, maleic, acetic, salicylic,p-toluene sulfonic, tartaric, citric, methane sulfonic, formic, malonic,succinic, naphthalene-2-sulfonic, and benzene sulfonic. Also,pharmaceutically acceptable salts can be prepared as alkaline metal oralkaline earth salts, such as sodium, potassium or calcium salts.

[0296] Suitable buffering agents include: acetic acid and a salt (1-2%W/V); citric acid and a salt (1-3% W/V); boric acid and a salt (0.5-2.5%W/V); and phosphoric acid and a salt (0.8-2% W/V).

[0297] Suitable preservatives include benzalkonium chloride (0.003-0.03%W/V); chlorobutanol (0.3-0.9% W/V); parabens (0.01-0.25% W/V) andthimerosal (0.004-0.02% W/V).

[0298] The active compounds of the present invention may be apharmaceutical composition having a therapeutically effective amount ofa conjugate of the invention optionally included in apharmaceutically-acceptable carrier. The term“pharmaceutically-acceptable carrier” as used herein means one or morecompatible solid or liquid filler, dilutants or encapsulating substanceswhich are suitable for administration to a human or other animal. Theterm “carrier” denotes an organic or inorganic ingredient, natural orsynthetic, with which the active ingredient is combined to facilitatethe application. The components of the pharmaceutical compositions arecapable of being commingled with the molecules of the present invention,and with each other, in a manner such that there is no interaction whichwould substantially impair the desired pharmaceutical efficacy.

[0299] Compositions suitable for parenteral administration convenientlycomprise a sterile preparation of the conjugates of the invention. Thispreparation may be formulated according to known methods. Formulationsfor taxanes can be found in Chapter 9 of Taxol: Science andApplications, CRC Press, Inc., 2000 Corporate Boulevard, N.W., BocaRaton, Fla. 33431. In general, Taxol has been formulated as a 6 mg/mlcremophor EL (polyoxyethylated castor oil)/ethanol mixture, which isdiluted to final volume with normal saline or 5% dextrose. A 15 mg/mlsolution of taxotere has been formulated in polysorbate 80(polyoxyethylene sorbitanmonooleate)/ethanol mixture, diluted with 5%dextrose.

[0300] The sterile preparation thus may be a sterile solution orsuspension in a non-toxic parenterally-acceptable diluent or solvent. Inaddition, sterile, fixed oils are conventionally employed as a solventor suspending medium. For this purpose any bland fixed oil may beemployed including synthetic mono or di-glycerides. In addition, fattyacids such as oleic acid find use in the preparation of injectables.Carrier formulations suitable for oral, subcutaneous, intravenous,intramuscular, etc. can be found in Remington's Pharmaceutical Sciences,Mack Publishing Company, Easton, Pa.

[0301] A subject as used herein means humans, primates, horses, cows,pigs, sheep, goats, dogs, cats and rodents.

[0302] The conjugates of the invention are administered in effectiveamounts. An effective amount means that amount necessary to delay theonset of, inhibit the progression of, halt altogether the onset orprogression of or diagnose the particular condition being treated. Ingeneral, an effective amount for treating cancer will be that amountnecessary to inhibit mammalian cancer cell proliferation in-situ. Whenadministered to a subject, effective amounts will depend, of course, onthe particular condition being treated; the severity of the condition;individual patient parameters including age. physical condition, sizeand weight; concurrent treatment; frequency of treatment; and the modeof administration. These factors are well known to those of ordinaryskill in the art and can be addressed with no more than routineexperimentation. It is preferred generally that a maximum dose be used,that is, the highest safe dose according to sound medical judgment.

[0303] Dosage may be adjusted appropriately to achieve desired druglevels, locally or systemically. Generally, daily oral doses of activecompounds will be from about 0.01 mg/kg per day to 1000 mg/kg per day.It is expected that IV doses in the range of about 1 to 1000 mg/m² perday will be effective. In the event that the response in a subject isinsufficient at such doses, even higher doses (or effective higher dosesby a different, more localized delivery route) may be employed to theextent that patient tolerance permits. Continuous IV dosing over, forexample 24 hours or multiple doses per day are contemplated to achieveappropriate systemic levels of compounds.

[0304] A variety of administration routes are available. The particularmode selected will depend of course, upon the particular drug selected,the severity of the disease state being treated and the dosage requiredfor therapeutic efficacy. The methods of this invention, generallyspeaking, may be practiced using any mode of administration that ismedically acceptable, meaning any mode that produces effective levels ofthe active compounds without causing clinically unacceptable adverseeffects. Such modes of administration include oral, rectal, sublingual,topical, nasal, transdermal, intradermal or parenteral routes. The term“parenteral” includes subcutaneous, intravenous, intramuscular, orinfusion. Intravenous routes are preferred.

[0305] The compositions may conveniently be presented in unit dosageform and may be prepared by any of the methods well known in the art ofpharmacy. All methods include the step of bringing the conjugates of theinvention into association with a carrier which constitutes one or moreaccessory ingredients. In general, the compositions are prepared byuniformly and intimately bringing the compounds into association with aliquid carrier, a finely divided solid carrier, or both, and then, ifnecessary, shaping the product.

[0306] Compositions suitable for oral administration may be presented asdiscrete units such as capsules, cachets, tablets, or lozenges, eachcontaining a predetermined amount of the active compound. Othercompositions include suspensions in aqueous liquors or non-aqueousliquids such as a syrup, an elixir, or an emulsion.

[0307] Other delivery systems can include time-release, delayed releaseor sustained release delivery systems. Such systems can avoid repeatedadministrations of the active compounds of the invention, increasingconvenience to the subject and the physician. Many types of releasedelivery systems are available and known to those of ordinary skill inthe art. They include polymer based systems such as polylactic andpolyglycolic acid, polyanhydrides and polycaprolactone; nonpolymersystems that are lipids including sterols such as cholesterol,cholesterol esters and fatty acids or neutral fats such as mono-, di andtriglycerides; hydrogel release systems; silastic systems; peptide basedsystems; wax coatings, compressed tablets using conventional binders andexcipients, partially fused implants and the like. In addition, apump-based hardware delivery system can be used, some of which areadapted for implantation.

[0308] A long-term sustained release implant also may be used.“Long-term” release, as used herein, means that the implant isconstructed and arranged to deliver therapeutic levels of the activeingredient for at least 30 days, and preferably 60 days. Long-termsustained release implants are well known to those of ordinary skill inthe art and include some of the release systems described above. Suchimplants can be particularly useful in treating solid tumors by placingthe implant near or directly within the tumor, thereby affectinglocalized, high-doses of the compounds of the invention.

[0309] The conjugates of the invention also are useful, in general, fortreating mammalian cell proliferative disorders other than cancer,including psoriasis, actinic keratosis, etc. They further are useful intreating diabetes and its complications, excess acid secretion,cardiovascular conditions involving cholesterol (e.g., hyperlipidemiaand hypercholesterolemia), diarrhea, ovarian diseases (e.g.endometriosis, ovarian cysts, etc.) and as contraceptive agents.

[0310] Those skilled in the art will be able to recognize with no morethan routine experimentation numerous equivalents to the specificproducts and processes described above. Such equivalents are intended tobe included within the scope of the appended claims.

We claim as follows:
 1. A method for targeting a pharmaceutical agent toa noncentral nervous system tissue to treat a noncentral nervous systemcondition comprising: administering to a subject in need of suchtreatment a covalent conjugate of a C8-26, unbranched, naturallyoccurring fatty acid and a pharmaceutical agent effective for treatingsaid condition provided that the drug is not an adenosine receptoragonist or antagonist.
 2. The method of claim 1 , wherein the tissue isbreast tissue and wherein the subject has a condition calling fortreatment of breast tissue with the pharmaceutical agent.
 3. The methodof claim 1 , wherein the tissue is gastrointestinal tissue and whereinthe subject has a condition calling for treatment of gastrointestinaltissue with the pharmaceutical agent.
 4. The method of claim 1 , whereinthe tissue is ovarian tissue and wherein the subject has a conditioncalling for treatment of ovarian tissue with the pharmaceutical agent.5. The method of claim 1 , wherein the pharmaceutical agent is anoncentral nervous system active agent that is nonactive within thecentral nervous system.
 6. The method of claim 1 , wherein the drug isan anti-cancer agent.
 7. The method of claim 1 , wherein the fatty acidis selected from the group consisting of C8:0 (caprylic acid), C10:0(capric acid), C12:0 (lauric acid), C14:0 (myristic acid), C16:0(palmitic acid), C16:1 (palmitoleic acid), C16:2, C18:0 (stearic acid),C18:1 (oleic acid), C18:1-7 (vaccenic), C18:2-6 (linoleic acid), C18:3-3(α-linolenic acid), C18:3-5 (eleostearic), C18:3-6 (δ-linolenic acid),C18:4-3, C20:1 (gondoic acid), C20:2-6, C20:3-6 (dihomo-y-linolenicacid), C20:4-3, C20:4-6 (arachidonic acid), C20:5-3 (eicosapentaenoicacid), C22:1 (docosenoic acid), C22:4-6 (docosatetraenoic acid), C22:5-6(docosapentaenoic acid), C22:5-3 (docosapentaenoic), C22:6-3(docosahexaenoic acid) and C24:1-9 (nervonic).
 8. The method of claim 1, wherein the fatty acid is selected from the group consisting of C14:0(myristic acid), C16:0 (palmitic acid), C16:1 (palmitoleic acid), C16:2,C18:0 (stearic acid), C18:1 (oleic acid), C18:1-7 (vaccenic), C18:2-6(linoleic acid), C18:3-3 (α-linolenic acid), C18:3-5 (eleostearic),C18:3-6 (δ-linolenic acid), C18:4-3, C20:1 (gondoic acid), C20:2-6,C20:3-6 (dihomo-y-linolenic acid), C20:4-3, C20:4-6 (arachidonic acid),C20:5-3 (eicosapentaenoic acid), C22:1 (docosenoic acid), C22:4-6(docosatetraenoic acid), C22:5-6 (docosapentaenoic acid), C22:5-3(docosapentaenoic), and C22:6-3 (docosahexaenoic acid).
 9. Apharmaceutical preparation comprising: a covalent conjugate of a C8-C26uunbranched, naturally occurring fatty acid and a noncentral nervoussystem active agent, and a pharmaceutically acceptable carrier.
 10. Thepharmaceutical preparation of claim 9 , wherein the fatty acid isselected from the group consisting of C8:0 (caprylic acid), C10:0(capric acid), C12:0 (lauric acid), C14:0 (myristic acid), C16:0(palmitic acid), C16:1 (palmitoleic acid), C16:2, C18:0 (stearic acid),C18:1 (oleic acid), C18:1-7 (vaccenic), C18:2-6 (linoleic acid), C18:3-3(α-linolenic acid), C18:3-5 (eleostearic), C18:3-6 (δ-linolenic acid),C18:4-3, C20:1 (gondoic acid), C20:2-6, C20:3-6 (dihomo-y-linolenicacid), C20:4-3, C20:4-6 (arachidonic acid), C20:5-3 (eicosapentaenoicacid), C22:1 (docosenoic acid), C22:4-6 (docosatetraenoic acid), C22:5-6(docosapentaenoic acid), C22:5-3 (docosapentaenoic ), C22:6-3(docosahexaenoic acid) and C24:1-9 (nervonic).
 11. The pharmaceuticalpreparation of claim 9 , wherein the fatty acid is selected from thegroup consisting of C14:0 (myristic acid), C16:0 (palmitic acid), C16:1(palmitoleic acid), C16:2, C18:0 (stearic acid), C18:1 (oleic acid),C18:1-7 (vaccenic), C18:2-6 (linoleic acid), C18:3-3 (α-linolenic acid),C18:3-5 (eleostearic), C18:3-6 (δ-linolenic acid), C18:4-3, C20:1(gondoic acid), C20:2-6, C20:3-6 (dihomo-y-linolenic acid), C20:4-3,C20:4-6 (arachidonic acid), C20:5-3 (eicosapentaenoic acid), C22:1(docosenoic acid), C22:4-6 (docosatetraenoic acid), C22:5-6(docosapentaenoic acid), C22:5-3 (docosapentaenoic ), and C22:6-3(docosahexaenoic acid).
 12. The pharmaceutical agent of claims 9-11,wherein the noncentral nervous system active agent is active on a tissueselected from the group consisting of: Blood and Blood Forming tissue;Cardiovascular system tissue; Digestive and excretory system tissue;Endocrine system tissue; Musclar system tissue; Reproductive Systemtissue; Respiratory system tissue; Skeletal system tissue; and Fiber andintegumentary system tissue.